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CHAPTER I 
I N T R O D U C T I O N 
It is now generally accepted that protein biosynthesis occurs on ribosomes 
in the presence of aminoacyl-t-RNA and messenger RNA, the latter bearing 
the genetic code reprinted from DNA. A review of the recent knowledge of 
the mechanism of protein biosynthesis was given by Konings (1969). 
It is clear that there has to be some regulatory mechanism to provide that 
the whole process occurs as efficiently as possible. The assumption can be made 
that RNA synthesis and RNA breakdown are in some way involved in this regu-
latory mechanism. Once synthesised the messenger RNA, responsible for the 
synthesis of a special protein, has to be inactivated when the cell does not re-
quire that special protein any longer. Therefore the assumption can be made 
that the regulation of the breakdown of messenger RNA is important for the 
regulation of protein biosynthesis. 
Since RNase is one of the RNA degrading enzymes and RNase inhibitors 
determine the level of RNase activity in the cell one might assume that RNase 
inhibitors also play a role in the regulation of protein biosynthesis. 
The aim of the present investigation was to isolate and characterise RNase 
inhibitor from rat liver and to provide more evidence for its functional role in 
protein biosynthesis. 
The enzymes involved in RNA degradation are discussed in Chapter II and 
most of the RNases so far known are listed. 
In Chapter III special attention is paid to bovine pancreatic RNase as this 
enzyme was used in the characterization of the RNase inhibitor. 
An account of the materials and methods used in this investigation is 
presented in Chapter IV. 
The isolation procedure of the RNase inhibitor is described in Chapter V. 
In Chapter VI a further characterization of the RNase inhibitor from rat 
liver is given. 
In Chapter VII the effect of the RNase inhibitor on the integrity and the 
amino acid incorporation ability of polyribosomes is described and experimen-
tal evidence is given for its regulatory role in protein biosynthesis in vitro. 
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CHAPTER II 
ENZYMES INVOLVED IN RNA DEGRADATION 
2.1. INTRODUCTION 
Enzymes catalysing the breakdown of ribonucleic acid are widely distributed 
in nature. There are two possible modes of action in RNA degradation : the 
first being hydrolysis and the second being phosphorolysis. 
The enzymes which hydrolyse RNA by the cleavage of phosphodiester inter-
nucleotide linkages can be divided into two main groups: 
1. the endonucleases which attack linkages in the interior of the nucleic acid 
chain by breaking it into fragments which may vary in size from mononucleo­
tides up to acid-precipitable polynucleotides. These endonucleases are called 
ribonucleases. 
2. the exonucleases which attack polynucleotides by the consecutive splitting of 
mononucleotides from one end of the chain. These enzymes are frequently 
referred to as phosphodiesterases. 
The enzymes degrading RNA by phosphorolysis are called polynucleotide 
phosphory'lases. 
The following groups of enzymes envolved in RNA degradation will there­
fore be briefly discussed in this chapter: 
a. Ribonucleases 
b. Phosphodiesterases 
с Polynucleotide phosphorylases. 
2.2. RIBONUCLEASES 
The presence of ribonuclease has been demonstrated in microorganisms, 
plants and many animal tissues. Unfortunately only a few of these ribo­
nucleases have been brought up to a state of purity sufficient for the determina­
tion of structural characteristics, substrate specificities and other properties. 
Tables 1, 2 and 3 list most of them, so far characterised from microorganisms, 
plants and animal tissues respectively. 
As can be seen from these tables the RNases now known may be 
divided into two groups. The first are characterised by an acid pH optimum 
and therefore are often called acid RNases and the second group consisting of 
RNases with an alkaline pH optimum, called alkaline RNases. All higher plants 
contain only acid RNases. 
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From molecular weights of RNases so far known one might conclude two 
classes of RNases existing, the first having a molecular weight of about 10,000 
to 12,000 and the second of about 30,000-40,000. 
With regard to their observed specificities one can divide RNases into 
three groups: the^rí í having no base-specificity (includes most microbial and 
all plant RNases), the second group exhibiting specificity for phosphodiester 
bonds which involve pyrimidine nucleosides (all known animal RNases 
belong to this group), and the third group of RNases which are only able to 
attack purine nucleoside phosphate linkages (all other microbial RNases). 
Most ribonucleases have been shown to degrade RNA in a similar way as 
does bovine pancreatic ribonuclease (chapter III), releasing З'-nucleotides via 
the formation of ribonucleoside-2',3'-cyclic phosphates. 
However some of the ribonucleases mentioned produce nucleoside-5'-phos-
phates, for example the Escherichia coli RNase II (Lehman, 1963), rye grass 
RNase (Roth, 1959) and the RNase from chicken pancreas, Ehrlich ascites 
tumor cells, pig liver nuclei, rat liver membranes and mitochondria, and sheep 
kidney (Shugar and Sierakowska, 1967). 
2.3. PHOSPHODIESTERASES 
The phosphodiesterases are nonspecific enzymes attacking both ribo- and 
deoxyribo-internucleotide bonds (Schmidt and Laskowski, 1961, Khorana, 
1961, Shugar and Sierakowska, 1967). The RNA breakdown, catalysed by these 
enzymes, occurs by a consecutive splitting of a mononucleotide from either the 
З'-end or the 5'-end of the chain, releasing 5' and З'-phosphates respectively. 
Their mode of action is schematically expressed in fig. 1. 
r\J r>P. NJ 
S. 
'\J Γ>Ρ. ^ N 
-OH 
H O - 1 
p
^ 
4 . . V . V . S, 
>J ^ ^ 
4 _ 
Kxl 
-он -он -он -он 
41 K\l K\J K\l 
-OH 
HO- HO- 1 HO- 1 HO-
Kp к 
HO-
3'-monophosphate3 5 - monophosphates 
FIG. 1. Reaction mechanism of phosphodiesterases. 
A pentanucleotide will be hydrolysed at the points shown by the dotted lines by phospho­
diesterases releasing nucleoside-S'-phosphates and nucleoside-3'-phosphates respectively. 
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TABLE 1. Physical and enzymic properties of various ribonucleases (Micro-organisms) 
Source 
Aspergillus oryzae 
(Takadiastase) 
heat acid 
RNase pH opt. stability stability MW 
Τ, 7.5 + 11,000 
inhibitors 
heavy metal ions 
(Takadiastase) 4.5 + 36,200 heavy metal ions 
Aspergillus saitoi 
Azotobacter agilis 
(vinelandii) 
Bacillus subtilis 
(extracellular) 
Bacillus subtilis 
(intracellular) 
Escherichia coli 
ribosomes 
M 4.0 + + 
7.0-7.5 
7.5-8.5 
5.8 
8.1 
+ 
± 
— 
+ 
30,000 
10,700 
PCMB, heavy meta 
ions 
A-2'-p, A-3'-p, A-5' 
Mn2 +, Zn2+, Cu 2 + 
EDTA, PCMB 
heavy metal ions 
EDTA 
Mn2 +, Co 2 +, Mg 2 + 
Escherichia coli В г-RNase 7.4-7.8 + 
ribosomes 
Escherichia coli В 
debris 
d-RNase 7.4-7.8 
Mn2+, Co 2 + 
Mn2 +, Co 2 + 
Escherichia coli super- II 
natant and ribosomes 
7.0-8.0 EDTA 
Neurospora crassa 
extracellular 
intracellular 
intracellular 
Streptomyces albogri- — 
ceolus (extracellulair) 
Streptomyces erylhreus 
(extracellulair) 
Ustilago sphaerogena 
(extracellulair) 
yeast (intracellulair) — 
Tetrahymena pyriformis 
N, 
N2 
N3 
 
— 
U, 
U 2 
U3 
U 4 
 
— 
7.0 
8.0 
6.0-7.0 
7.5 
7.3-7.4 
8.0 
4.5 
4.5 
8.0 
7.3 
5.0-5.5 
+ 
— 
— 
+ 
+ 
+ 
r 
+ 
no 
no 
+ 
+ 
— 
— 
+ 
+ 
_ 
— 
— 
— 
— 
11,000 
> 36,000 
11,000 < N 3 < 36,000 
— 
— 
± 10,000 
± 10,000 
-fc 10,000 
much larger 
— 
— 
Hg2 +, other divalen 
cations 
EDTA 
— 
metal ions 
— 
AgNOj, CUSO4 Zn 
AgNCb, CuSO« 
AgNOj, CUSO4 
AgNOj, CUSO«, 
Zn2 +, Mg2+, Mn 2 + 
metal ions (esp. Zn2 
EDTA, Cu2+ 
tivators insensitive to specificity other properties references 
DTA 
DTA 
DTA 
a*. Mg^ 
a2+, Ba2+, 
+, Na+ 
Ig2+, Ca2+, 
a2+, Na+ 
gî+, Ca 2 \ 
a2+, Na+ 
+(orNH«+) 
g2+, Mn2+ 
SSO«, 
H2COOH 
DTA 
DTA 
H2PO4 
PCMB, DFP, 
heparin, natural 
inhibitors 
DFP, histidine 
— 
— 
EDTA 
— 
EDTA 
— 
— 
Zn2+, EDTA 
EDTA 
EDTA 
— 
PCMB 
EDTA, 
EDTA, 
PCMB 
EDTA, 
PCMB 
PCMB 
PCMB 
G 
A 
non-specific 
non-specific 
non-specific 
non-specific 
non-specific 
high molecular 
RNA 
A > G 
low molecular 
RNA 
A>G 
non-specific 
G 
non-specific 
G 
G 
G 
G 
purine bases 
purine bases 
non-specific 
non-specific 
non-specific 
very acidic prot. 
2 disulph. bonds 
neutral protein 
— 
— 
no disulph. bonds 
inhibitor present 
very basic protein 
produces 3'-phosph. 
— 
only active in presence 
of K+; produces 
5'-phosph. 
resembles Ti 
resembles T2 
resembles Ti 
RNase T, like 
acidic protein 
— 
— 
Uchida and Egami (1966); Egami, 
Takahashi and Uchida (1964); 
Anfinsen and White (1961); 
Egami and Nakamura (1969) 
Lazarus and Scherbaum (1967); 
Egami, Takahashi and Uchida 
(1964); Anfinsen and White (1961); 
Egami and Nakamura (1969) 
Egami and Nakamura (1969); 
Irie (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969); 
Nishimura (1966); 
Anfinsen and White (1961) 
Egami and Nakamura (1969); 
Smeaton and Elliott (1967) 
Spahr (1966);Egami andNakamura 
(1969); Spahr and Hollingworth 
(1961); Elson (1958); Elson (1959); 
Lehman (1963) 
Anraku and Mizuno (1965); Anraku 
and Mizuno (1967); Lehman (1963); 
Egami and Nakamura (1969) 
Anraku and Mizuno (1965); Anraku 
and Mizuno (1967); Lehman (1963); 
Egami and Nakamura (1969) 
Lehman (1963); Egami and 
Nakamura (1969); Spahr (1966) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Egami and Nakamura (1969) 
Anfinsen and White (1961); Roth 
(1959); Lazarus and Scherbaum 
(1967) 
TABLE 2. Physical and enzymic properties of various ribonucleases (Higher plants) 
Source 
Pea leaves 
Rye grass 
Spinach leaves 
Tobacco leaves 
Wheat seedlings 
RNase 
I 
I 
II 
II 
I 
II 
pH opt. 
5.1-5.5 
4.5-5.1 
6.0 
5.0-6.3 
5.1 
6.0 
5.2 
heat 
stability 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
acid 
stability 
— 
— 
— 
— 
+ 
MW inhibitors 
divalent cations 
Zn2+, Mn2-·-, NaF, KH2P 
EDTA, DTT, 2-mE, cystei 
TABLE 3. Physical and enzymic properties of various ribonucleases (Animals) 
Source 
heat acid 
RNase pH opt. stability stability MW inhibitors 
Bovine pancreas IA 7.8 13,683 Ca2+, Mg2+, 
Bovine pancreas 
Bovine liver 
Bovine spleen 
Calf spleen 
Chicken liver 
Chicken pancreas 
Erhlich ascites plasma 
tumor cells 
Frog liver 
Guinea pig liver 
Guinea pig serum 
Hamster liver 
Human urine 
Mouse kidney 
Mouse liver 
Mouse liver 
Mouse lung 
IB 
acid 
alkal. 
acid 
alkal. 
alkal. 
neutr. 
— 
acid 
alkal. 
acid 
alkal. 
acid 
alkal. 
acid 
alkal. 
alkal. 
acid 
7.8 
7.5-7.8 
5.8-6.5 
5.6-5.8 
7.8 
5.8 
7.8 
8.7 
7.2 
7.3 
7.8 
5.8 
7.8 
5.8. 
7.8 
7.4 
5.8 
7.8 
5.8 
7.8 
7.9 
7.8 
5.8 
6.8-7.5 
+ 
+ 
idem 
+ 
EDTA 
+ 
ivators insensitive to specificity 
other 
properties 
g2+, Ca", Co2+, Fe2+, 
i+, K+, NH4+ Ni 2 + ,Ca 2 + 
non-specific 
non-specific 
non-specific 
non-specific 
non-specific 
non-specific 
references 
references 
Anfinsen and White (1961); Reddi (1966) 
Roth (1959) 
Reddi (1966) 
Anfinsen and White (1961); Reddi (1966) 
Roth (1959); Anfinsen and White (1961); 
Reddi (1966) 
Roth (1959); Anfinsen and White (1961); 
Reddi (1966) 
Hanson and Fairly (1969) 
tivators insensitive to specificity 
other 
properties references 
i2+ PCMB 
«xidation 
U.C. 
U.C. 
U,C. 
4 disulph. 
bonds basic 
protein 
aient 
tions 
Ca2+ non-specific — 
Mg2+, NaF — 
White and Anfinsen (1959); Roth (1959); 
Anfinsen and White (1961); Klee (1966); 
Morrill and Reiss (1969); Shugar and 
Sierakowska (1967); Dickman, Morrill and 
Trupin (1960) 
Plummer and Hirs (1964); Beintema (1966) 
Shugar and Sierakowska (1967) 
Shugar and Sierakowska (1967); Roth (1959) 
Maver et al. (1959); Bernardi (1966) 
Maveret al. (1959); Anfinsen and White (1961) 
Roth (1959) 
Roth (1959) 
Heller and Kulka (1968); Shugar and 
Sierakowska (1967); Eley (1969) 
Heller and Kulka (1968) 
Ellem, Colter and Kuhn (1959) 
Shugar and Sierakowska (1967); Ellem, 
Colter and Kuhn (1959) 
Roth (1962) 
Roth (1962) 
Roth (1962) 
Roth (1962); Shugar and Sierakowska (1967) 
Anfinsen and White (1961) 
Roth (1962) 
Roth (1962) 
Anfinsen and White (1961); Hakim (1959) 
Anfinsen and White (1961); Hakim (1959) 
Ellem, Colter and Kuhn (1959) 
Ellem, Colter and Kuhn (1959); Roth (1962) 
Ellem, Colter and Kuhn (1959) 
Ellem, Colter and Kuhn (1959) 
heat acid 
Source RNase pH opt. stability stability MW inhibitors 
Mouse pancreas 
Mouse pancreas 
acid 
alkal. 
5.0 
7.8 + 
Mouse peripheral lymf nodes — 6.8-7.4 — 
Mouse intestinal mucosa 
Mouse salivary gland 
Mouse serum 
Mouse spleen 
Mouse thymus 
Pig liver nuclei 
Pig liver nuclei 
Pig liver nuclei 
Pig liver ribosomes 
Rat adipose tissue 
Rat adipose tissue 
Rat adrenals 
Rat adrenals 
Rat bone marrow 
Rat brain 
Rat brain 
Rat hepatoma 
Rat kidney 
Rat kidney 
Rat liver 
— 
— 
— 
— 
— 
— 
— 
— 
— 
I 
II 
I 
II 
I 
II 
— 
I 
II 
I 
6.8-7.4 
7.8 
7.3 
6.7-7.4 
5.6-7.1 
5.4 
6.4 
7.2-S.O 
6.4-6.8 
5.8-6.3 
7.5-8.2 
5.6 
7.8 
5.2-5.5 
5.8 
8.0 
7.8 
5.6-6.0 
7.8 
5.5 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
_ 
— 
— 
+ 
+ 
+ 
+ 
— 
— 
— 
— 
— 
— 
no 
— 
— 
— 
— 
_ 
— 
— 
+ 
no 
Rat liver 
Rat liver 
Rat liver lysosomes 
Rat liver membranes 
Rat liver mitochondria 
Rat liver ribosomes 
Rat liver supemate 
Rat serum 
II 
III 
7.8 
9.5 
5.8 
7.8 
6.8 
8.0 
7.5-8.0 
7.8 
+ 
+ 
low 
+ 
+ 
CaI+, Mg2+ 
Ca1+, Mg2+ 
Ca2+, Mg2+, 
NaCl above 
0.2 M 
EDTA, Ca2+, 
Mg2+ 
NaCl above 
0.2 M 
NaCl, divalen 
cations, EDT 
Mg2 
+ 
Sheep kidney 
Sheep pancreas 
7.0-7.5 
7.0-8.0 
other 
ivators insensitive to specificity properties references 
U.C. 
•
2+
, Mn2+, 
2+ 
EDTA 
Dickman and Morrill (1959) 
Dickman and Morrill (1959); Anfinsen and 
White (1961); Ellem, Colter and Kuhn 
(1959); Dickman and Trupin (1958); 
Dickman, Morrill and Trupin (I960) 
Dickman, Morrill and Trupin (1960) 
Ellem, Colter and Kuhn (1959) 
Ellem, Colter and Kuhn (1959) 
Ellem, Colter and Kuhn (1959) 
Ellem, Colter and Kuhn (1959) 
Ellem, Colter and Kuhn (1959) 
Martin et al. (1963) 
Martin et al. (1963) 
Martin et al. (1963); Shugar and 
Sierakowska (1967); Heppel (1966) 
Martinetal. (1963) 
Eley (1969) 
Eley (1969) 
Girija and Sreenivasan (1966) 
Girija and Sreenivasan (1966) 
Minguell and Perretta (1967) 
de Lamirande and Allard (1959) 
de Lamirande and Allard (1959) 
Anfinsen and White (1961) 
Roth (1957) 
Roth (1957) 
Rahmann (1966); Roth (1954); Roth (1956); 
Shugar and Sierakowska (1967); 
de Lamirande and Allard (1959) 
Rahmann (1966); Roth (1954); Roth (1956); 
de Lamirande and Allard (1959); Beintema 
(1966) 
Rahmann (1966) 
i1+, Mn2+ — 
TA — 
non-specific — 
Mg2+, EDTA, 
PCMB, 
2-mE, KCl 
î2+ , Mn2+ non-specific — 
Roth (1959) 
Shugar and Sierakowska (1967); de Lamirande 
et al. (1966) 
Shugar and Sierakowska (1967); Roth (1959) 
de Lamirande et al. (1966) 
Shugar and Sierakowska (1967); Roth (1956); 
Roth (1954); Roth (1962); Roth (1959) 
Umeda et al (1969) 
Shugar and Sierakowska (1967) 
Anfinsen and White (1961 ; Âqvist and 
Anfinsen (1959) 
2.3.1. Phosphodiesterases releasing nucleoside-5'-phosphates 
Two well-known representatives of phosphodiesterases hydrolysing RNA in­
to S'-mononucIeotides are snake venom phosphodiesterase desciibed by Cohn 
and Volkin (1953), Hilmoe (1959) and Khorana (1961) and intestinal phospho­
diesterase purified by Heppel and Hilmoe (1953, 1955) from intestinal mucosa. 
Enzymes resembling the snake venom phosphodiesterase were found in nearly 
all tissues (Shugar and Sierakowska, 1967). In general these enzymes were found 
to be heat-labile and optimally active at about pH 9. These enzymes only 
attack chains terminating in a 5'-phosphate terminal group, whereas chains 
terminating in a З'-phosphate group are relatively resistant. 
A detailed review of these enzymes was given by Khorana (1961). 
2.3.2. Phosphodiesterases releasing nucleosides'-phosphates 
Phosphodiesterases releasing nucleoside-3'-phosphates are widely distributed 
in animal tissues (Heppel and Hilmoe, 1953, Razzell, 1961) but the most striking 
example of this class of enzymes is the phosphodiesterase isolated from spleen 
by Heppel and Hilmoe (1953) and Hilmoe (1960). It is heat-labile, has an op­
timum at pH 6 and releases З'-mononucleotides from the 5'-hydroxyl end of 
the chain, whereas 5'-phosphate-terminated chains are resistant. It is often 
referred to as phosphodiesterase II. 
This class of enzymes was also reviewed by Khorana (1961). 
2.3.3. Cyclic nucleotide phosphodiesterases 
Not only the ribonucleases discussed above are capable of hydrolysing ribo-
nucleoside 2',3'-cyclic phosphates to the corresponding З'-phosphates. Enzymes 
have been reported from a variety of sources that seem to be specific for the 
hydrolysis of cyclic esters. There are two kinds of cyclic nucleotide phospho­
diesterases, those hydrolysing 2',3'-cyclic phosphates and those hydrolysing 
3',5'-cyclic phosphates. 
2.3.3.1. Phosphodiesterases hydrolysing ribonucleoside 2',3'-cyclic phosphates 
Distinct from the major phosphodiesterase activity crude snake venom has 
an activity that hydrolyses purine and pyrimidine ribonucleoside 2',3'-cyclic 
phosphates to the corresponding З'-phosphates (Dekker, 1954). 
Preparations of spleen phosphodiesterase, discussed above, also contain 
a phosphodiesterase that hydrolyses the ribonucleoside 2',3'-cyclic phosphates 
to give ribonucleoside 2'-phosphates (Whitfield, Heppel and Markham, 1955). 
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Similar activities, capable of hydrolysing the cyclic phosphates to the 2'- or 
З'-phosphates, have been reported in intestinal mucosa and rye grass (Whitfield, 
Heppel and Markham, 1955), beef pancreas and beef brain (Davis and Allen, 
1956). 
These enzymes are inert towards internucleotide linkages and 3',5'-nucleo-
tides. 
2.3.3.2. Phosphodiesterases hydrolysing ribonucleoside 3',5'-cyclic phosphates 
An enzyme hydrolysing 3',5'-cyclic phosphates to the corresponding 5'-phos-
phates, was found in various tissues and most abundant in brain (Butcher 
and Sutherland, 1962, Sutherland and Rail, 1960). It is inert towards inter­
nucleotide linkages and 2',3'-phosphates. 
Nair (1966) partially purified a similar enzyme from dog heart hydrolysing 
3',5'-dAMP more rapidly than 3',5'-AMP. A second analogous enzyme was 
purified from dog heart by Hardmann and Sutherland (1965). It is considered 
to be a different enzyme from that found by Nair for it hydrolyses 3',5'-UMP 
at a rate fourfold that of 3',5'-AMP and 20 times that of 3',5'-CMP and this 
enzyme was partially separated from Nair's by the use of ammonium sulphate. 
2.4. POLYNUCLEOTIDE PHOSPHORYLASES 
Polynucleotide Phosphorylase was first discovered in Azotobacter agilis by 
Grunberg-Manago and Ochoa (1955) and also purified from Escherichia coli 
(Littauer and Romberg, 1957). The enzyme is widely distributed among aerobic 
and anaerobic bacteria, as reviewed by Grunberg-Manago (1963). 
Polynucleotide Phosphorylase catalyses the reversible reaction 
Mg2+ 
n N P P ^ ( N P )
n
+ n P i 
where Ρ is phosphate, Pi inorganic orthophosphate, and N represents a purine 
or pyrimidine nucleoside (Grunberg-Manago, 1961, 1963). In the forward reac­
tion polyribonucleotides are synthesized from nucleotide 5'-diphosphates, with 
elimination of inorganic orthophosphate; in the reverse reaction polyribonu­
cleotides are phosphorolysed to yield nucleoside 5'-diphosphates. 
We shall not discuss here the polymerization reaction but only pay attention 
to the phosphorolyzation reaction. 
Singer (1958) investigated the specificity of the phosphorolysis reaction and 
concluded the oligonucleotides with 5'-phosphomonoester end groups were 
rapidly phosphorolysed, but those having З'-monoester end groups were re­
sistant to enzymic attack. The 5'-phosphate group is not essential for activity, 
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however, since oligonucleotides with no monoester phosphate such as trinu-
cleoside diphosphates, are phosphorolysed, whereas dinucleotides and dinucleo-
side monophosphates are not attacked. 
The mechanism of phosphorolysis was examined by limited exposure of small 
well-known oligonucleotides such as pApApApA and pApApApU to phospho­
rolysis (Hilmoe, 1959; Singer et al, 1960). In the incubation mixture containing 
pApApApU the mononucleotide first produced was UDP, when incubation 
was prolonged ADP was also formed so they suggested a stepwise phosphoroly-
tic cleavage. 
Pi Pi 
pApApApU • pApApA > pApA 
+ + 
UDP ADP 
So phosphorolysis of polynucleotides proceeds in a stepwise manner, be­
ginning at the end of the chain that has a free З'-hydrosyl group and proceeds 
only to the dinucleotide or dinucleoside monophosphate level. The dinucleotide 
or dinucleoside-monophosphates are not further attacked. 
The phosphorolysis of high-molecular weight polynucleotides, such as RNA, 
is a more complex problem. Factors such as molecular configuration interfere 
with phosphorolysis of these polymers. Polymers that can assume a multi-
stranded configuration are, under certain conditions, resistant to phosphoro­
lysis. In contrast to homopolymers such as poly A, which are readily phos­
phorolysed copolymers such as poly AU or poly AGUC are phosphorolysed 
much more slowly (Grunberg-Manago, 1963). In addition, with exception of 
TMV-RNA, the rate of phosphorolysis of various RNA preparations is gene­
rally even lower (Grunberg-Manago et al. 1955, Littauer and Kornberg, 1957; 
Grunberg-Manago, 1959; Ochoa, 1957). 
2.5. F U N C T I O N OF RNA D E G R A D I N G ENZYMES 
During the last few years, numerous studies on nucleic acids have demon­
strated the important role of the RNA-degrading enzymes. With advances in 
research on nucleic acids interest in the metabolism of nucleic acids has in­
creased and consequently various kinds of enzymes participating in the break­
down of nucleic acids have been found and studied. 
However, no distinct results on the precise role of RNA-degrading enzymes 
have yet been obtained. Therefore the information available at present will be 
summarised and some hypotheses based on this information will be considered. 
Various experiments on bacteria, most of them on Escherichia coli support 
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the possibility that RNA-degrading enzymes participate in some essential reac­
tions in nucleic acid metabolism such as breakdown of messenger RNA after 
use in protein synthesis and the turnover of transfer- and ribosomal-RNA under 
certain growth conditions. 
2.5.1. Breakdown of messenger RNA 
During exponential growth of bacterial cells m-RNA appears to be meta-
bolically unstable. Artman and Engelberg (1964, 1965) showed in in vitro expe­
riments that purified E. coli RNase I, as well as the ribosomal fraction, had 
activity to degrade m-RNA. 
Three phenomena also observed by other investigators demonstrated the 
participation of RNase I in m-RNA turnover in E. coli in vitro: (a) There is 
0.1 molecule of this enzyme per 70 S particle in cell extracts (Spahr and Holling-
worth, 1961) (b) The 30 S components to which RNase I is attached also com­
bine with m-RNA (Okamoto and Takanami, 1963; Wettstein et al (1963), 
(с) RNase I appears to be inactive to ribosomal RNA under physiological con­
ditions (Spahr and Hollingworth, 1961). 
However, the hypothesis that RNase I might be involved in m-RNA degra­
dation received a major set back by their in vivo experiments on spheroplasts, 
prepared under conditions in which they scarcely contained any RNase I acti­
vity. In calculating the half-life time of the m-RNA they found the same value 
for both the RNase I free preparation and the normal one. Gasteland (1966) 
isolated an E. coli mutant lacking RNase I activity. In measuring the half-life 
time of the m-RNA he obtained the same value for the mutant and the wild-
type E. coli. 
If RNase I does not participate in degradation of m-RNA what enzyme does 
attack m-RNA in normal cells? 
Sekiguchi and Cohen (1963) first implicated polynucleotide Phosphorylase 
as the enzyme responsible for the degradation of m-RNA. They observed the 
rapidly labelled RNA formed after the infection of E. coli with Te-phage, i.e. 
phage specific m-RNA, being chiefly broken down to nucleoside 5'-diphosphates 
and 5'-monophosphates. The reaction required inorganic phosphate and 6-aza 
UDP, a well-known inhibitor of polynucleotide Phosphorylase, had a strong 
inhibitory effect. They also reported a kind of phosphodiesterase, bound to the 
ribosomes, taking part in the degradation of m-RNA. This phosphodiesterase 
was later shown to be RNase II by Singer and Tolbert (1965). Thus in phage-
infected cells polynucleotide Phosphorylase and RNase II seem to be the 
enzymes responsible for m-RNA breakdown. 
Barondes and Nirenberg (1962) showed that polynucleotide Phosphorylase 
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was involved in the breakdown of poly U, utilised as an artificial messenger 
in a cell-free system for protein synthesis. 
However, the possible role, if any, of polynucleotide Phosphorylase in the 
degradation of m-RNA in higher organisms is not clear, since it is not detec­
table in most animal tissues (Grunberg-Manago, 1963). For some time poly­
nucleotide Phosphorylase was thought to be the enzyme responsible for RNA 
synthesis in a variety of micro-organisms. The reason of this assumption was 
its efficient in vitro catalysis of the synthesis of long-chain polyribonucleotides. 
However, there is now general agreement that its in vivo role in micro-organ­
isms is most probably a catabolic one (Grunberg-Manago, 1963). 
2.5.2. Ribosomal-RNA 
Ribosomal-RNA is thought to be completely conserved in normal cells as 
well as in virus-infected cells (Brenner et al., 1961). But it is obviously damaged 
under limited growth conditions such as phosphorus deficiency, in which the 
content of ribosomal RNA per cell decreased markedly, though the amounts 
of other kinds of RNA's (transfer-RNA and messenger-RNA) are constant 
(Maruyama and Mizuno, 1965). The degradation products are a mixture of 
З'-phosphate and 2',3'-cyclic phosphate. The proportion of cyclic phosphates 
decreased with time, showing properties strikingly like those of in vitro digestion 
by RNase I. From these investigations the authors concluded that under limited 
growth conditions, ribosomal-RNA is degraded by the action of RNase I. 
The remarkable in vitro stability of the ribosomes of an E. coli mutant lacking 
RNase 1 (Gasteland, 1966), is in agreement with this hypothesis. Degradation 
of ribosomal-RNA in RNase I lacking bacteria is shown in in vitro experiments 
to occur in Pseudomonas aeruginosa by polynucleotide Phosphorylase (Gronlund 
and Campbell, 1965) and in Alkaligenes faecalis by RNase II and polynucleo­
tide Phosphorylase (Natori et al., 1967). 
2.5.3. Transfer-RNA 
Transfer-RNA, like ribosomal-RNA, is thought to be stable in cells in the 
normal state. If degradation of t-RNA occurs Egami and Nakamura (1969) 
suggested RNase I to be the enzyme responsible, because of the great effect of 
secondary structure of RNA on the activities of polynucleotide Phosphorylase 
and RNase II as pointed out by Ochoa (1957). But there is no experimental 
evidence to support this suggestion. 
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2.6. REGULATION OF RNA DEGRADING ENZYMES 
In view of the problem as to how the activities of the enzymes degrading 
RNA are controlled in the cell, several possible mechanisms may be considered : 
1. The existence of specific inhibitors for the enzymes. 
2. The protection of RNA by some cellular components or structures. 
3. Limitation of enzyme activity by the structure of RNA. 
4. The intracellular location of the enzymes and substrates. 
5. The concentrations of the substrates, products and effectors. 
2.6.1. Specific inhibitors 
A specific RNase inhibitor was detected by Roth (1956) in rat liver super-
natant. A similar activity was found in Aspergillus oryzae by Nozumi and 
Arrima (1966) and Bacillus subtilis by Smeaton and Elliott (1967a, b). In all 
three cases the inhibitor has a proteinlike character. Such inhibitors may play 
a regulatory role in RNA metabolism and through that in protein biosynthesis. 
2.6.2. Protection of RNA by cellular structures 
In Escherichia coli RNase I is known to be latent when it is bound to ribo-
somes. Spahr and Hollingworth (1961) and Anraku and Mizuno (1965, 1967) 
showed that the 30 S compounds of ribosomes can adsorb externally added, 
purified RNase I, whereas bovine pancreatic RNase and RNase Ti are not 
adsorbed at all. Thus the mechanism of adsorption of RNase on 30 S particles 
seems to be a species-specific process. 
The ribosomal structure protects RNA from enzymatic degradation, the 
ribosomal RNA is resistant to enzyme attack, being bound to basic protein in 
the ribosomes (Neu and Heppel, 1964). Even poly U is protected by ribosomes 
from degradation by RNase II (Castles and Singer, 1969). Schlessinger (1963) 
observed in Bacillus megaterium the membrane-bound polyribosomes to be 
protected from nuclease attack. 
2.6.3. Limitation of enzyme activity by RNA structure 
The enzyme polynucleotide Phosphorylase is known to be less active against 
RNA of ordered configuration, like t-RNA, than with randomly coiled poly-
nucleotides (Grunberg-Manago, 1963). 
2.6.4. The intracellular localization of enzymes and substrates 
An important possible control mechanism is the intracellular localization of 
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the RNA degrading enzymes but one has to be careful with localization data 
from isolation procedures because of the possible contamination during such 
procedures. 
Reid and Nodes (1959) localised acid liver RNase in the lysosomes. Martin 
et al. (1963) described an acid RNase in pig liver nuclei, and alkaline RNase 
both in the nuclei and ribosomes. 
In rat liver acid RNase was detected in the lysosomes by Roth (1959) whereas 
alkaline RNase was localised in membranes (Shugar and Sierakowska, 1967), 
deLamirandeetal.í^óT^nmitochondriaíRoth, 1959, Shugar and Sierakowska, 
1967) in the ribosomes (de Lamirande et al., 1967) and in the supernatant (Roth 
1954, 1956, 1959, 1962, Shugar and Sierakowska, 1967). 
2.6.5. The concentrations of the substrates, products and effectors 
Finally the concentrations of the substrates, products and possible effectors 
within the cells have to be taken into account, but it is clear that this is a pro-
blem difficult to solve in vivo and no data are available at the present time. 
In summary, the various regulation mechanisms mentioned above for in vitro 
systems may act concomitantly in vivo. 
26 
CHAPTER IH 
BOVINE PANCREATIC RIBONUCLEASE 
3.1. INTRODUCTION 
Bovine pancreatic ribonuclease is the best known of all ribonucleases. It was 
first crystallised by Kunitz (1940). It can easily be isolated by extraction with 
0.25 N-sulphuric acid and precipitation of the extract with ammonium sulphate 
between 0.6 and 0.8 saturation. This procedure by Kunitz followed by a heating 
step introduced by McDonald (1948) yields a homogeneous preparation without 
proteolytic activity. 
Ribonuclease is stable over a wide pH range and is resistant to heat in 
slightly acid solution although it is readily inactivated by alkali. It has no action 
on DNA. Its maximum activity is in the pH range of 7.0-8.2 with the optimum 
at pH 7.7. 
Firstly in this chapter the structure of pancreatic ribonuclease will be dis-
cussed, secondly its mode of action on RNA and thirdly factors which affect 
its activity. 
3.2. STRUCTURE 
3.2.1. Amino acid composition 
The amino acid composition of bovine pancreatic ribonuclease was determi-
ned by Hirs et al. (1956,1960). The enzyme contains one hundred and twenty-
four amino acid residues per mole which are shown to be arranged in a single 
polypeptide chain. All eight of the halfcystine residues are involved in disulphide 
bonds since no free SH groups can be detected. Numbering from the N-terminal 
end of the chain the four disulphide bridges are located between cystine 26 and 
cystine 86, cystine 40 and cystine 95, cystine 58 and cystine 120, and cystine 
65 and cystine 72. 
A schematic diagram of bovine pancreatic ribonuclease showing the complete 
sequence of amino acid residues and the location of the four disulphide bonds 
is shown in fig. 2. 
Plummer and Hirs (1964) demonstrated that bovine pancreas contains an-
other minor ribonuclease component; they called it ribonuclease B. It only 
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differs from the above mentioned nbonuclease A by containing a side chain 
of 6 monosaccharides on asparagin-34, resulting in a different chromatographic 
behaviour. 
FIG 2 Schematic diagram of bovine pancreatic nbonuclease, showing the complete sequence 
of ammo acid residues and the locations of the four disulphidc bonds (Reproduced from 
Anfinsen and White, 1961) 
3 2 2 Active centre 
Anfinsen (1956) demonstrated that limited digestion with pepsin inactivated 
nbonuclease by liberating a tetrapeptide from the C-terminal end The fourth 
residue from the C-terminal end, aspartic acid, seems to be associated with 
nbonuclease activity as removing only three amino acids from the C-terminal 
end by carboxypeptidase treatment has no effect on the activity 
Richards et al (1959, 1962) showed that proteolysis of nbonuclease A by 
subtihsin at low temperature results m cleavage of a single peptide bond be-
tween ammo acid residues 20 and 21 without loss of enzymic activity The two 
parts in the resulting RNase S molecule, however, are still tightly bonded to-
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gether by non-covalent bonds. By treatment of the RNase S molecule with 
trichloroacetic acid it can be resolved into two parts, the small one containing 
the amino acid residues 1 to 20 (called S-peptide) and the large one comprising 
residues 21 to 124 (S-protein). Both the S-peptide and S-protein are enzymically 
inactive but the activity is completely restored on remixing equimolar amounts 
of S-peptide and S-protein resulting in RNase S'. Takahashi et al. (1969) de­
monstrated that RNase A, RNase S and RNase S' showed an identical pH 
optimum of 8.0 when RNAw as used as a substrate. Whenever low-molecular 
weight compounds were used as substrates the pH optimum for the three enzymes 
shifted respectively to 5.5 for RNase A, 6.5 for RNase S, and between 6.5 
and 5.5 for RNase S'; these shifts in pH optimum were less remarkable at 
37° С than at 160C. The three enzymes show also different heat sensitivities. 
RNase-S-protein is readily digestible by trypsin in contrast with RNase A 
but RNase activity is not restored by addition of S-peptide to the digest. 
Richards also subjected RNase-S-peptide to the action of trypsin and chymo-
trypsin with the complete loss of reactivating ability. 
Gross and Witkop (1967) used the bacterial proteinase Nagarse instead of 
subtilisin in preparing the S-peptide. Nagarse released a mixture of 2 S-pep-
tides: the one containing amino acids 1-20 and the other with the sequence 
1-21. Cleavage of the Nagarse S-peptides with cyanogen bromide results in a 
mixture of a heptapeptide (14-20) and an octapeptide (14-21). They concluded 
the sequence 15-20 contributed little to the activity of the enzymes since the 
reconstituted ribonucleases S', missing the 15-20 or 16-20 amino acid sequence, 
are as active as the normal S' ribonucleases. 
In a review article Anfinsen and White (1961) showed histidine, lysine and 
cystine to be involved in enzymatic activity. 
From carboxymethylation experiments with iodoacetate Scheraga (1967) con­
cluded that both histidine residues 12 and 119 were at the active site whereas 
Lys 41 was probably located near but not in the active site. Other groups that 
might be near or at the active site are Arg 10, Туг 115 and Asp 121. 
In their work on enzymatic activity of partially synthesized ribonuclease 
Marzotto et al. (1967) modified synthetically the S-peptide resulting in [Lys10]-
S-peptide, the [Orn10]-S-peptide and the [Om1 0, Glu11]-S-peptide. In recon­
stituting the enzyme by combination of the S-protein with the modified S-pep­
tides the resulting S'-ribonuclease is active but in comparison with the normal 
S'-ribonuclease the change in one or two amino acids was sufficient to give rise 
to different kinetic characteristics and different binding constants. 
Lack of progress in the preparation of a small active fragment is probably 
due to the fact that several parts of the ribonuclease molecule, widely separated 
in terms of sequential position in the chain appeared to be involved in the active 
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centre of the enzyme and can act compatibly only under conditions of reason­
ably intact secondary and tertiary structure. 
3.3. REACTION MECHANISM 
Bovine pancreatic ribonuclease catalyses the hydrolysis of ribonucleic acid 
in a two-step reaction. 
The first step - the fastest - is a transphosphorylisation reaction and consists 
of the cleavage of the phosphodiester bonds that involve the nucleotides of 
cytosine and uracil, resulting in the formation of 2'-3'-cyclic phosphate esters 
of the pyrimidine nucleosides as terminal groups on intermediate oligonucleo­
tide fragments. These pyrimidine 2'-3'-cyclic phosphates are then split off (when 
the preceeding unit in the RNA chain contains pyrimidine). This first step has 
frequently been referred to as a 'depolymerisation' reaction. 
In the second step - much slower - the free pyrimidine 2'-3'-cyclic phosphates 
are hydrolysed with the formation of the corresponding pyrimidine-3'-phos-
phates. 
The reaction mechanism is visualised in fig. 3. 
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FIG. 3. Hydrolysis of ribonucleic acid catalyzed by bovine pancreatic ribonuclease. 
In the first step - a transphosphorylisation reaction - oligonucleotides, terminating in 
pyrimidine 2'-3'-cyclic phosphates, are formed. These pyrimidine 2'-3'-cyclic phosphates are 
then split off. 
In the second step - a much slower reaction - the free 2'-3'-cyclic phosphates are hydrolysed 
with the formation of the corresponding pyrimidine-3'-phosphates (Reproduced from Anfin-
sen and White, 1961). 
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In his study of the role of the pyrimidine base in the ribonuclease reaction 
Witzel (1963) concluded that the pyrimidine base only was involved in the 
catalysis and did not participate in the binding of the substrate to the enzyme. 
Therefore the binding equilibrium, postulated from Michaelis-Menten kinetics, 
cannot be explained by the existence of an association complex but rather by 
a complex in which, with the binding, an acetylation of the phosphorus occurs. 
The increase of electrophilicity of the phosphorus required for the reaction is 
furnished by the enzyme through a protonation. The function of the pyrimidine 
base can be seen as an alternate base-acid catalysis. This role depends on a 
steric requirement that the base holds the proton of the 2'OH group between the 
attacking and the leaving oxygens. This cannot be done by the purine bases. 
Further details of the mechanism of the ribonuclease reaction were elaborated 
by Witzel's group (Gassen and Witzel, 1967; Follmann, Wicker and Witzel, 
1967 and Wicker and Witzel, 1967). 
The same conclusion, the pyrimidine ring of nucleotides interacting with a 
basic group at the 3 or 4 position of the protein of the RNase was made by 
Deavin et al. (1968) in spectrophotometric investigations of the interaction of 
the enzyme with nucleotides. 
NMR studies on the structure of the active site of pancreatic ribonuclease A 
by Rüterjans and Witzel (1969) are in agreement with the proposed binding 
process in which histidine 119 and lysine 41 are the binding groups of the en-
zyme, whereas histidine 12 takes up a proton when being released from its bind-
ing to histidine 119. 
Heppel et al. (1955a) demonstrated that ribonuclease catalyses the formation 
of cytidine-3'-methyl-phosphate from cytidine-2'-3'-phosphate and methanol 
and a similar reaction with the uridine derivative and also with ethanol in stead 
of methanol. Ribonuclease was also found to catalyse the synthesis of poly-
nucleotides from cyclic cytidylic acid (cytidine-2'-3'-phosphate), evidence for 
the synthesis of the dinucleotide, cyclic dinucleotide and cyclic trinucleotide has 
been presented (Heppel et al., 1955b). 
3.4. FACTORS AFFECTING RIBONUCLEASE ACTIVITY 
3.4.1. Introduction 
The greatest problem in the isolation of native RNA is the presence of 
RNases and other nucleolytic enzymes. RNases are generally present in an in-
active state because of the presence of an inhibitor (Roth, 1956) or because 
they are compartmentalized in organelles such as the lysosomes but they may 
be activated or released in the course of tissue fractionation. Most of the RNase 
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inhibitors now known are listed below but one has to take into account the 
fact that they are not useful to the same extent in the isolation of undegraded 
RNA. 
3.4.2. Polyanions 
3.4.2.1. Naturally occurring polyanions 
a. Bentonite. The diatomaceous earth bentonite is probably the most successful 
agent for removing RNase. Jacoli (1968) demonstrated that the inactivation of 
the enzyme could not be attributed solely to an ion-exchange effect because 
vermiculite, which is a clay with higher cationic capacity than bentonite, showed 
very little inactivation of RNase. The spatial arrangement of the clay matrix 
must play an important role. RNase must enter the interlayer spacings of ben-
tonite because of their expansion ability to react with the ionic groups and little 
or no adsorption occurs on the surface of the clay. Inactivation of the enzyme 
by photo-oxydation did not alter the retention of RNase by bentonite. The 
conditions employed are important, particularly pH and salt concentration 
(Roth, 1967). 
b. Heparin. The inhibitory action of heparin was discovered independently by 
Roth (1953) and Zöllner and Fellig (1953). Heparin is a strongly acidic poly-
saccharide of complex structure containing sulphonic acid and sulphamide 
groups as well as carboxyl groups. The inhibition is of the competitive type 
and takes place between the sulphamate groups of heparin and the dissociated 
secondary phosphate groups of the nucleic acid. Heparin inhibits both steps of 
the RNase reaction, the second step being more strongly inhibited. 
3.4.2.2. Synthetic polyanions 
Synthetic polyanions like polyvinylsulphate (Littauer and Sela, 1962; Kreche-
tova et al., 1963) polyglucose sulphate (Mora and Young, 1959) and amino acid 
copolymers (Sela, 1962) also seem to provide good protection against RNases. 
3.4.3. Polycations 
Polycations such as protamine, polylysine, spermidine and spermine have 
also been used as RNase inhibitors (Tabor and Tabor, 1965; Erdmann et al., 
1968, and Goldstein, 1969) but polyamines appear to inhibit RNases by binding 
with RNA. 
3.4.4. Metalions 
3.4.4.1. Magnesium 
The concentrations of Mg2+ ions required to give significant inhibition of 
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bovine pancreatic RNase are quite high, in the range of 75 mM (Wojnar and 
Roth, 1964). Nishimura and Novelli (1963) reported that enzymic digestion of 
tRNA by bovine pancreatic RNase was markedly inhibited by 0.01 M Mgì+, 
whereas only modest inhibition was observed with high molecular weight yeast 
RNA as substrate. 
3.4.4.2. Manganese and Calcium 
Mn2+ and Ca2+ ions gave similar results as Mg2+. Mg2+ or other divalent 
cations increase Tm of tRNA by causing an increase in ordered helical structure, 
thus decreasing the susceptibility of the RNA to the enzyme (Nishimura and 
Novelli, 1963). 
3.4.4.3. Mercury, Silver and Indium 
These ions were reported by Singer and Fraenkel-Conrat (1962) to react with 
TMV-RNA and prevented subsequent action of either pancreatic RNase or 
purified plant nuclease. 
3.4.4.4. Copper and Zinc 
Cu2+ and Zn2+ ions have exceptionally high inhibitory action on bovine pan-
creatic RNase. The effect would appear to be due to combination of the enzyme 
with metal ions although this is by no means certain (Wojnar and Roth, 1964). 
A combination of Zn2+ ions and bentonite was used by Brownhill et al. (1959) 
to prepare undegraded RNA and ribonucleoproteins from yeast. 
3.4.5. Mononucleotides 
The inhibitory effect of many nucleotides on bovine pancreatic RNase was 
first reported by Zittle and Reading (1945) and has since then been studied by 
many investigators (Davis and Allen, 1956; Myer and Schellman, 1961; Hum-
mel et al., 1958a,b, 1961 and by Nelson and Hummel, 1961). The concentra-
tions of nucleotide required for effective inhibition are quite high. Dinucleoside, 
mono- and diphosphates and trinucleoside phosphates might be bound to the 
enzyme with greater specificity and hence might be more inhibitory (Nagyvary, 
1966). 
3.4.6. Naturally occurring RNase inhibitors 
3.4.6.1. Ribonuclease inhibitor from Bacillus subtilis 
Smeaton and Elliott (1967a, b) reported the presence of a ribonuclease inhi-
bitor in Bacillus subtilis cells during the production of extracellular ribonuclease 
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towards the end of the growth phase. It has no action on pancreatic ribonu-
clease or Takadiastase ribonuclease T. They have been able to purify the inhi-
bitor and have shown it to have the properties of a protein with molecular weight 
of 12,500. 
3.4.6.2. RNase inhibitor from plant leaves 
Bernheimer and Steele (1955) examined a whole series of higher plants for 
the presence of RNase inhibitor. Only the extracts from lilac (Syringa vulgaris) 
leaves and privet (Ligustrum vulgare) leaves appeared to inhibit degradation 
of RNA by pancreatic ribonuclease by reacting with the enzyme. 
3.4.6.3. Ribonuclease inhibitor from mammalian tissues 
Pirotte and Desreux (1952) first described the occurrence of an RNase in-
hibitor in guinea pig supernatant. 
Since then it was also found in rat liver (Roth, 1956) in mouse ascites tumour 
cells (Colter et al., 1961), rat adipose tissue (Eichel et al., 1961), mouse brain 
(Llamas and Coronas, 1961), human blood (Gupta and Herriott, 1963), rat 
adrenal supernatant (Girija and Sreenivasan, 1966) and rabbit reticulocytes 
(Traub et al. 1966). 
The most well known of all these animal RNase inhibitors is the one isolated 
from rat liver. It will be discussed in further detail in the following chapters. 
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CHAPTER IV 
MATERIALS AND METHODS USED FOR THE 
ISOLATION AND CHARACTERIZATION OF THE 
RNASE INHIBITOR FROM RAT LIVER 
4.1. INTRODUCTION 
The existence of an RNase inhibitor in rat liver was demonstrated by Roth 
(1956). A partial purification was achieved by Roth (1958), Shortman (1961) 
and Bont et al. (1965, 1969). In our isolation procedure the results obtained 
by these authors are taken into account. Some of the first purification steps are 
partially based on their results. 
In this chapter an account of the methods used for the isolation and charac­
terization of the RNase inhibitor from rat liver will be given. 
4.2. PREPARATION OF SUBCELLULAR FRACTIONS 
The livers used in our studies were from 2-3 month-old male Wistar albino 
rats (weight approximately 200 g). 
In order to avoid contamination of the preparations by liver glycogen, the 
animals were starved overnight before being killed. 
4.2.1. The 100,000 g supernatant fraction of rat liver 
The animals were killed by decapitation. The livers were quickly excised and 
immersed in ice-cold isolation medium (0.35 M sucrose in 0.05 M Tris-HCl 
buffer, pH 7.6, 0.025 M potassium chloride, 0.01 M magnesium chloride). All 
subsequent operations were carried out at 0-4° С 
The livers (about 200 g) were minced with scissors and homogenised with 
2.5 volumes of isolation medium. The homogenization was performed by using 
a Teflon homogenizer and five strokes at 2,000 revolutions per minute were 
applied. 
The homogenate was centrifuged at 12,000 g for 20 minutes in a Sorvall 
GSA rotor to remove nuclei, mitochondria and cell debris. 
The resulting 12,000 g supernatant was decanted and centrifuged at 100,000 g 
for 2 hours in a No. 40 rotor of a Spinco model L preparative ultracentrifuge. 
The supernatant is further referred to as the 100,000 g supernatant fraction. 
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4.2.2. Rat liver polyribosomes 
For the isolation of rat liver polysomes 15 ml of the 12,000 g supernatant 
fraction (prepared as described above 4.2.1) were applied to a discontinuous 
sucrose gradient, consisting of 2 layers of 10 ml of 2 M and 1.5 M sucrose both 
in a medium consisting of 0.05 M Tris-HCl buffer, pH 7.6, 0.025 M KCl and 
0.01 M MgCb. The sucrose gradients were then centrifuged at 75,000 g for 
16 hours at 2° С (Spinco rotor 30) according to the method of Bloemendal et 
al. (1964, 1967) and Benedetti et al. (1966). 
After centrifugation the polysomal pellets were suspended in the required 
medium. 
4.2.3. Calf lens polyribosomes 
For the isolation of calf lens polyribosomes eyes of one-day old calves 
were used. After the animals were killed in the slaughter-house the eyes were 
quickly removed and the lenses were isolated as soon as possible at 0oC. The 
capsules containing the epithelial cells were collected at 0oC. The outer cortex 
was obtained by punching out a 1-2 mm thick layer from the equator with the 
aid of a glass trephine. Capsules and outer cortex were homogenised in one 
volume of ice-cold medium (consisting of 0.05 M Tris-HCl buffer pH 7.6, 
0.025 M KCl and 0.008 M MgCh). The homogenate was centrifuged at 12,000 g 
for 20 minutes at 2° С in a Sorvall preparative centrifuge (GSA rotor). 
The 12,000 g supernatant was used for the isolation of polyribosomes. After 
addition of sodium deoxycholate (final concentration 0.5%) samples of 15 ml 
were subjected to centrifugation on discontinous sucrose gradients essentially 
by the same method as described for the isolation of rat liver polyribosomes 
(4.2.2). 
4.3. POLYACRYLAMIDE GEL ELECTROPHORESIS 
Electrophoresis was performed on cylindrical Polyacrylamide gels as des­
cribed by Bloemendal (1963). A 10% separating gel was used and electropho­
resis was carried out at pH 8.9 in Tris-EDTA-boric acid (L.K.B. high resolu­
tion buffer). 
Routinely 50-100 μg of protein dissolved in 10 μΐ of the electrophoresis 
buffer were layered on top of the gels with the aid of sucrose. 
Electrophoresis was carried out at 5 mA per tube. The runs were terminated 
when the tracking dye reached a position of 0.5 cm from the lower end of 
the gel. 
The gels were stained for 45 minutes in a solution containing 0.5% Amido-
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black В in 7 % acetic acid and 50 % methanol. Destaining was carried out by 
electrophoresis perpendicular to the length of the gels (25 m A per gel) in 2 % 
acetic acid and was accomplished within 30 minutes. 
4.4. SUCROSE DENSITY GRADIENT ANALYSIS 
For the analysis of polyribosomal profiles linear sucrose density gradients 
(10-30%) were prepared in 0.05 M Tris-HCl buffer pH 7.6, containing 0.025 M 
potassium chloride and 0.01 M magnesium chloride. Routinely 800-1000 μg of 
polyribosomes dissolved in 1 ml of the same buffer were carefully layered on 
top of the gradient. 
Centrifugation was carried out at 25,000 rpm for 1.5 hours at 2° С in a swing-
out rotor, type 25.1 of a preparative ultracentrifuge (Spinco L-50). 
After centrifugation the bottom of the gradient tube was punctured and frac­
tions of 10 droplets were collected. The absorbance at 260 nm of the fractions 
was measured with the aid of a Zeiss Spectrophotometer (type PMQ II). 
4.5. AMINO ACID INCORPORATION 
The amino acid incorporation was studied with polyribosomes derived from 
rat liver. 
The complete incubation mixture consisted of polyribosomes (200 μg RNA), 
1.25 цтоіев phosphoenolpyruvate, 0.125 цтоіе ATP, 0.063 цтоіе GTP, 0.69 
mg 2-mercaptoethanol, 12.5 μg pyruvate kinase (EC 2.7.2.40), 10 pmoles 
DL-l-^C leucine (specific activity 34 mCi/mmole), a mixture of unlabelled 
aminoacids (excluding leucine) 10 тцтоіез per amino acid, and cell sap from 
rat liver (approximately 1 mg of protein). All components were dissolved in 
medium В (containing 0.05 M Tris-HCl buffer pH 7.6, 0.008 M MgCb and 
0.025 M KCl. The final volume was 0.25 ml. Incubation was performed for 
45 min at 37° С 
The reaction was stopped by addition of 2 ml of 10% TCA. After centri­
fugation the precipitate was resuspended in 3 ml of 5 % TCA, boiled for 15 min 
at 90°С (to hydrolyse aminoacyl-tRNA) and poured onto millipore filters (dia­
meter 25 mm, pore size 0.45 μ). After repeated washing with 5% TCA the 
filters were placed in glass counting vials and dried at 65° for 30 minutes. As 
scintillation fluid, 10 ml of a solution of 0.3% PPO and 0.02% POPOP in 
toluene was used. Radioactivity was measured in a Packard Tri-carb liquid 
scintillation spectrometer (Model 4322). All assays were performed in duplicate. 
4.6. RNASE INHIBITOR ASSAY 
As the use of commercial yeast RNA as a substrate in our assay, resulted 
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in high background values, this preparation was repurified before use. The RNA 
was precipitated three times with 2.5 volumes of cold 96% ethanol. The preci­
pitate was dissolved in distilled water and low molecular weight components 
were removed by gel filtration on Sephadex G-50. The eluate was lyophilised. 
Thereafter the RNA was dissolved in distilled water and the concentration was 
adjusted to 1 %, assuming that RNA at a concentration of 1 mg per ml had an 
extinction of 25 at 260 nm. The RNA solution was stored in small portions 
at—20° С 
Crystalline pancreatic RNase (Boehringer) was dissolved in 0.1% gelatin 
solution to a concentration of 0.05 μg/ml. The gelatin solution used was dialysed 
againstO.01 M EDTA, to remove heavy metal ions, then against 0.15 M sodium 
chloride and finally against distilled water. The RNase-gelatin solution was 
stored in small portions at —20° C. 
The inhibitor activity was measured according to the method of Shortman 
(1961). However a 0.5 M Tris-HCl, pH 7.8, buffer was used instead of 0.03 M 
veronal acetate. This modification was introduced in order to diminish the 
sensitivity of the RNase inhibitor assay to changes in pH. Secondly the Tris-
buffer results in lower background values at 260 nm as compared with the 
veronal-acetate buffer. 
The incubation mixture contained 0.1 ml of a suitable dilution of the inhi­
bitor sample to be assayed, 0.1 ml of the RNase-gelatin solution and 0.2 ml 
of 0.5 M Tris-HCI buffer, pH 7.8. Finally 0.2 ml of the RNA solution (1 %) 
was added. The reaction mixture was incubated for 30 minutes at 37°C. 
The reaction was stopped by the addition with thorough mixing of 0.6 ml 
of 1 N HCl in 76% ethanol. After centrifugation at 2,000 g for 30 minutes at 
0-4° С an aliquot of 0.5 ml of the cleared supernatant was pipetted off and 
diluted with 2.5 ml of distilled water. The absorbance at 260 nm was measured 
in 0.5 cm cuvettes. 
Activity determinations of 0.005 μg of bovine pancreatic RNase in the ab­
sence of inhibitor (100% RNase activity, 0% inhibition) were run simultane­
ously together with blanks without RNase (0% RNase activity or 100% inhi­
bition. 
One unit of inhibitor is defined as the amount which causes a 50% inhibition 
of 0.005 μg RNase under standard conditions. 
All assays were performed in duplicate. 
4.7. DNASE I N H I B I T O R ASSAY 
The DNase inhibitor assay was carried out according to the method of Zalite 
and Roth (1964). 
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The incubation mixture consisted of 0.1 ml DNase solution (containing 
0.15 μg of pancreatic DNase), 0.2 ml of the sample to be tested, 0.2 ml of 
0.03 M MgCh, 0.5 ml of 0.05 M sodium phosphate buffer pH 7.0. Finally 
0.5 ml of a DNA solution (0.085 %) was added. 
The reaction mixture was incubated for 30 minutes at 37° С and the reaction 
was stopped by the addition of 1.5 ml of cold 10% PCA. After standing for 
10 minutes at 0 o C the mixtures were centrifuged at 1,000 g for 30 minutes. 
The absorbance of the cleared supernatant was measured at 260 nm in 0.5 cm 
cuvettes. 
All assays were performed in duplicate. 
4.8. DETERMINATION OF RNA CONCENTRATIONS 
RNA concentrations were measured by the absorbance at 260 nm with the 
aid of a Zeiss spectrophotometer (type PMQ II) and calculated on the assump­
tion that RNA at a concentration of 1 mg per ml had an extinction of 25. 
4.9. DETERMINATION OF PROTEIN CONCENTRATIONS 
Protein was determined according to the method of Lowry et al. (1951) 
using bovine serum albumin as a standard. 
4.10. MATERIALS 
In our experiments we used the following materials : 
Acrylamide - Union Chimique Belge. 
Amido Black - E. Merck A.G. 
ATP (kristall, dinatrium salz) - C. F. Boehringer und Soehne. 
Bovine Albumin - Nutritional Biochemicals Corporation. 
12C-Amino acids - Sigma. 
uC-Amino acids - The radiochemical Centre Amsterdam. 
CM-RNase (Enzite, batch R3) - Seravac Laboratories Ltd. 
DEAE-Sephadex A-50 (Capacity 3.5 ± 0.5 meq/g, particle size: 40-120 μ -
Pharmacia. 
DNA - Miles Laboratories Inc. 
DNase (EC. 3.1.4.5 pancreatic, RNase free) - Sigma. 
DOC - E. Merck A.G. 
DTT - Calbiochem. 
EDTA - E. Merck A.G. 
Folin Ciocalteus phenol reagent - E. Merck A.G. 
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GTP (trilithium salz) - С. F. Boehringer und Soehne. 
2-Mercaptoethanol - Koch Light Laboratories Ltd. 
Ν,Ν'-methylene-bisacryIamide - Schuchardt, München. 
PCA - E. Merck A.G. 
Phosphoenol pyruvic acid (trisodium salt-hydrate) - Sigma. 
POPOP (scintillation grade) - Packard Instrument Company Inc. 
PPO (FP 70-72° С for scintillation measurings) - E. Merck A.G. 
Pronase (Streptomyces griseus) - Serva. 
Pyruvate kinase (EC. 2.7.1.40) - С F. Boehringer und Soehne. 
RNA - Nutritional Biochemicals Corporation. 
RNase (cryst. bovine pancreatic) - C. F. Boehringer und Soehne. 
Sephadex G-25 (fine, particle size : 20-80 μ) - Pharmacia. 
Sephadex G-50 (medium, particle size- 50-150 μ) - Pharmacia. 
Sephadex G-100 (particle size: 40-120 μ) - Pharmacia. 
Sucrose (sugar cane) - BDH Chemicals Ltd. 
Trypsin (bovine pancreatic) - Nutritional Biochemicals Corporation. 
Media used 
Medium A: 0.05 M Tris-HCl buffer pH 7.6, 0.005 M 2-mercaptoethanol. 
Medium B: 0.05 M Tris-HCl buffer pH 7.6, 0.008 M MgCh, 0.025 M KCl. 
Medium С: 0.05 M Tris-HCl buffer pH 7.6, 10-3M DTT, 10-3M EDTA. 
Medium D: 0.05 M sodium phosphate buffer pH 6.0, lO^M DTT and 10-3M 
EDTA. 
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CHAPTER V 
ISOLATION OF THE RNASE INHIBITOR FROM RAT LIVER 
5.1. INTRODUCTION 
Since Pirotte and Desreux (1952) first described the occurrence of an RNase 
inhibitor in the high speed supernatant fraction from guinea pig liver, the 
presence of an RNase inhibitor was demonstrated in many other mammalian 
tissues as well in plants as in microorganisms (Chapter III). 
Both Roth (1958a) and Shortman (1961) isolated the RNase inhibitor from 
rat liver. Smeaton and Elliott (1967a, 1967b) achieved a partial purification of 
an RNase inhibitor from Bacillus subtilis. 
In order to study the properties of this factor with regard to RNase inhibition 
as well as its function in protein biosynthesis it is very important to have the 
RNase inhibitor in a state as pure as possible (see Chapter VII). 
An account of our isolation procedure will be described in this chapter. 
5.2. RAT LIVER RNASE INHIBITOR 
Roth (1956) characterised the RNase inhibitor of the high speed supernatant 
fraction from rat liver as a non-dialyzable, rather labile protein which could 
easily be inactivated by heat or acid treatment. The supernatant fraction appear-
ed to be active against crystalline bovine pancreatic RNase as well as alkaline 
RNase present in rat tissues. On the other hand no inhibition of the acid 
RNases could be observed. 
The inhibitory effect towards RNase was optimal at pH 7.8-8.0 and its 
activity depended on the presence of free-SH groups in the inhibitor. 
In the rat liver supernate large quantities of alkaline RNase appeared to be 
bound to RNase inhibitor (Roth 1956). Therefore the RNase inhibitor is present 
in the rat liver supernatant fraction partly in a free state and partly bound to 
alkaline RNase. The bound inhibitor could be inactivated by Pb24 ions and 
PCMB resulting in a release of the alkaline RNase. Similar inactivation of the 
inhibitor could not be achieved by iodoacetate or iodoacetamide (Roth, 1958b). 
A partial purification of the rat liver RNase inhibitor was obtained by Roth 
(1958a) using a combination of ammonium sulphate precipitation and calcium 
phosphate gel treatment. In this procedure a tenfold purification was achieved. 
Another purification procedure was developed by Shortman (1961) who 
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applied chromatography on DEAE-cellulose followed by chromatography on 
calcium phosphate gel. This procedure resulted in a 1000-fold purification of 
the RNase inhibitor as compared with the rat liver supernatant fraction. The 
author mentioned a decrease of the stability of the purified inhibitor during 
storage, heating, freezing and thawing and lyophylization especially after dilution. 
Both rat liver RNase inhibitor and heparin inhibited bovine pancreatic 
RNase but did not affect the activity of RNase Ti (an alkaline RNase from 
Aspergillus oryzae) or of several acid RNases derived from plant tissues. How-
ever both these inhibitors differed in their activity against rat liver RNase: the 
acid RNase was inhibited by heparin, but not by the rat liver inhibitor, whereas 
the alkaline RNase was inhibited by the rat liver inhibitor, but only slightly 
affected by heparin (Shortman 1962a). 
Partially purified rat liver inhibitor could be inactivated by low concentra-
tions of papain, trypsin, periodate, sulphydryl reactants and protamine and 
high salt concentrations. These results provide evidence for the protein nature 
of the rat liver RNase inhibitor (Shortman, 1962a). 
A number of other isolation techniques was used to isolate RNase inhibitor. 
Bont et al. (1965) applied isoelectric precipitation at pH 5 followed by ammo-
nium sulphate precipitation. A combination of chromatography on DEAE-cellu-
lose and gel filtration on Sephadex G-75 was used by Smeaton and Elliott 
(1967b) for the isolation of RNase inhibitor from Bacillus subtilis. Recently a 
combination of chromatography on CM-cellulose and preparative Polyacryl-
amide gel electrophoresis (slab technique) was used by Bont et al. (1969). An 
800-fold purification was recently achieved by Moriyama et al. (1969) applying 
precipitation at pH 5.0, calciumphosphate gel treatment and chromatography 
on DEAE-cellulose. 
The isolation procedure which was finally developed by us is partly based 
upon earlier results obtained by other authors. A preliminary account has been 
given previously (Gribnau et al., 1969). 
5.3. ISOLATION OF RAT LIVER RNASE INHIBITOR 
The RNase inhibitor was isolated from livers of 2 to 3 months-old male 
Wistar rats. The purification procedure described here was routinely carried 
out with the 100,000 g supernatant fraction derived from 50 livers (approxima-
tely 200 gram wet weight). 
5.3.1. The 100,000 g supernatant fraction 
The 100,000 g supernatant fraction was prepared as described in the methods 
section (Chapter IV). This fraction, used as the starting material, contained 
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approximately 16 to 18 grams of protein in a total volume of 500 to 600 ml. 
The specific RNase inhibitor activity, as determined in the standard RNase 
inhibitor assay (4.6), was found to be 4.5-6.7 units per mg of protein; the total 
inhibitor activity varied between 110,000 and 140,000 units. 
5.3.2. Ammonium sulphate precipitation 
The 100,000 g supernate was fractionated by ammonium sulphate precipita­
tion in order to find out whether this method could be applied as the first purifi­
cation step. 
Fractions were prepared by precipitation between 0-30%, 30-40%, 40-50%, 
50-60%, 60-70% and 70-100% saturation. Solid ammonium sulphate was 
added to the solution and the suspension was stirred at 0° for 30 minutes. The 
precipitates were collected by centrifugation at 12,000 g and suspended in 
75 ml of medium A containing the appropriate ammonium sulphate concen­
tration (medium A consisted of 0.05 M Tris-HCl buffer pH 7.6 and 0.005 M 
2-mercaptoethanol). After stirring for 30 minutes the washed precipitates were 
dissolved in 25 ml of medium A and desalted by dialysis against several changes 
of the same medium. 
The inhibitor activity of all six fractions was determined in the standard 
RNase inhibitor assay (4.6). The percentage of the total inhibitor activity re­
covered in each fraction is presented in fig. 4. 
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FIG. 4. RNase inhibitor activity from different ammonium sulphate precipitation fractions. 
Fractionation of the 100,000 g supernatant from rat liver by ammonium sulphate precipi­
tation was carried out as described in the text. 
After precipitation each fraction was desalted by dialysis and samples were tested in the 
standard incubation mixture, as described in chapter IV.6. 
The percentage of the total RNase inhibitor activity recovered in each fraction was calcul­
ated. 
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In the fractions precipitating between 0-30% and 70-100% ammonium sul­
phate saturation no inhibitor activity could be detected. 
The highest activity was observed in the fraction precipitating between 50 
and 60% ammonium sulphate saturation. However a considerable activity was 
also present in fractions precipitating at somewhat lower and higher ammonium 
sulphate concentrations. 
In view of these findings we decided to use precipitation between 35 and 
65% ammonium sulphate saturation as the first step in our isolation procedure. 
The resulting precipitate was dissolved in a minimal volume of medium A, 
containing 0.1 M NaCl and 10-3M EDTA. The protein solution (approxima­
tely 100 ml) was desalted on a Sephadex G-25 column (80 X 3 cm) equilibrated 
in the same medium A - NaCl - EDTA solution. The protein fractions emerg­
ing at the void volume of the column were combined to yield the 35-65% am­
monium sulphate fraction. 
Routinely the 35-65% ammonium sulphate fraction contained 8-10 gram of 
protein with a specific activity of 6.5-7.9 inhibitor units per mg of protein. The 
total inhibitor activity recovered after gel filtration on Sephadex G-25 varied 
between 60,000 and 90,000 inhibitor units. 
5.3.3. Chromatography on DEAE-Sephadex 
The active fraction obtained after gel filtration on the Sephadex G-25 column 
was directly loaded onto a column of DEAE-Sephadex A-50 (17 X 2.5 cm), 
equilibrated in medium A containing 0.1 M NaCl and 10_ 3M EDTA. Under 
these ionic conditions about 80% of the total protein applied onto the column 
was not adsorbed to DEAE-Sephadex and was present in the efiluent. 
The column was washed with the initial buffer until the absorbancy at 280 nm 
decreased to 0.05. Then a stepwise elution with 0.15 M NaCl in medium A 
containing 10~3M EDTA was performed. A sharp peak absorbing at 280 nm 
was then eluted. 
Thereafter the column was developed with a linear NaCl concentration gra­
dient, the mixing chamber contained 150 ml of 0.15 M NaCl and the reservoir 
150 ml of 1.0 M NaCl, both in medium A containing 10-3M EDTA. 
The elution was accomplished at 4°С at a flow rate of about 20 ml/hr. 
Fractions of 2.5 ml were collected. 
A typical elution pattern is shown in fig. 5. 
All fractions were tested for inhibitor activity. The bulk fraction (fractions 
10 90) representing 80% of the total protein applied onto the column did not 
reveal any inhibitor activity. A negligable activity was observed in the peak 
eluting at 0.15 M NaCl (fractions 90-110). The major activity was located in 
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the two protein peaks eluted after starting the gradient (fractions 155-176). The 
last peak, emerging at a 0.6 M NaCl concentration represented transfer RNA. 
The active fractions (155-176) were combined, thoroughly dialysed against 
distilled water and lyophilised. 
In previous experiments a linear gradient was applied directly after the initial 
washing of the column with 0.1 M NaCl in medium A containing 10~3M EDTA, 
thereby omitting the intermittant elution step with 0.15 M NaCl. However, 
despite the total activity recovered by this procedure was quite similar, the 
specific activity was found to be lower. 
As determined by the standard RNase inhibitor assay the active fractions 
obtained after DEAE-Sephadex chromatography had a specific activity of 
200-350 units per mg of protein. The protein recovered was 250-300 mg which 
corresponded to 2.5% of the total protein loaded onto the column. 
The yield of inhibitor activity was 40,000-60,000 units which corresponded 
to a recovery of about 60-70 % of the total units applied onto the column. 
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FIG. 5. Chromatography on DEAE-Sephadex A-50 of the 35-65% ammonium sulphate fraction. 
After desalting on Sephadex G-25, the 35-65 % ammonium sulphate fraction was directly 
loaded onto a column of DEAE-Sephadex A-50 (17 x 2 5 cm), equilibrated m medium A 
containing 0.1 M NaCl and lO^M EDTA (medium A consisted of 0.05 M Tns-HCl buffer 
pH 7.6 and 0.005 M 2-mercaptoethanol). 
At arrow I the protein was applied onto the column. 
At arrow II elution was performed with 0.15 M NaCl in medium A containing lO-^M 
EDTA. 
At arrow III a linear gradient was started ranging from 0.15 to 1 0 M NaCl in medium A 
containing 10_:,M EDTA. Both the mixing chamber and the reservoir contained 150 ml. 
Fractions of 2 5 ml were collected. 
The RNase inhibitor activity was located in fractions 155 to 176. 
% transmittance at 280 nm. 
sodium chloride concentration (M). 
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5 3 4 Rechromatography on DEAE-Sephadex 
Several methods can be used to achieve further purification of the RNase 
inhibitor after chromatogiaphy on DEAE-Sephadex. 
However chromatography of the active DEAE-Sephadex fraction on aCM-
cellulose column, which was successfully applied by Bont et al (1969) at a 
much lower purification level, did not result in a significant improvement of 
the specific activity 
As the RNase inhibitor activity coincided with two piotein peaks whereas 
its maximum was found in between (compare fig 5) we tried to find out whether 
rechromatography on DEAE-Sephadex might result in an increased purification 
of the inhibitor. 
In this procedure the active fractions, obtained after chromatography on 
DEAE-Sephadex, were combined After thorough dialysis against medium A 
containing 0 1 M NaCl and 10~3M EDTA ,the active protein was loaded onto 
a second column of DEAE-Sephadex A-50 (17 X 2 5 cm), equilibrated in me­
dium A containing 0 1 M NaCl and 10-3M EDTA. After washing with the 
same solution a small sharp protein peak was eluted with 0 15 M NaCl in 
medium A containing 10~3M EDTA. The column was then developed with a 
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FIG 6 Rechromatography on DEAE-Sephadex A-50, of the DEAE-Sephadex RNase inhibitor 
fraction 
The DEAE-Sephadex RNase inhibitor fraction was rechromatographed on a column of 
DEAE-Sephadex A-50 (17 χ 2 5 cm), equilibrated in medium A containing 0 1 M NaCl and 
10- 3M EDTA 
AH protein and RNase inhibitor was adsorbed onto the column under these circumstances. 
At arrow I the column was washed with 0 15 M NaCl in medium A containing lO'-'M 
EDTA 
At arrow II a linear gradient was started ranging from 0 15 M NaCl to 0 3 M NaCl, both 
in medium A containing 10~3M EDTA Both the mixing chamber and the reservoir contained 
150 ml. 
Fractions of 2 5 ml were collected 
The RNase inhibitor activity was located in fractions 65-140. 
absorbance at 280 nm 
sodium chloride concentration (M) 
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linear NaCl concentration gradient, the mixing chamber containing 150 ml of 
0.15 M NaCl and the reservoir 150 ml of 0.3 M NaCl both in the same medium 
A containing 10~3M EDTA. 
The elution was accomplished at 4° С at a flow rate of about 20 ml per hour. 
Fractions of 2.5 ml were collected. 
The elution pattern is shown in fig. 6. 
All fractions were tested for RNase inhibitor activity. The activity was located 
in fractions 65-140. The active fractions were combined, dialysed against distil­
led water and lyophilised. 
By this procedure the specific activity, being 200-350 after the first chromato­
graphy on DEAE-Sephadex, increased to about 450 units per mg of protein. 
The recovery of the total units was about 65 %. 
As judged by Polyacrylamide gel electrophoresis some slow-moving bands 
were eliminated by this rechromatography procedure. As these protein compo­
nents were also removed by gel filtration on Sephadex G-100 (5.3.5) and there 
was a loss of another 35 % of the total inhibitor units we omitted this rechro­
matography step in our routine purification procedure. 
5.3.5. Gel filtration on Sephadex G-100 
Up to 100 mg of the lyophilised active material obtained after DEAE-Se­
phadex A-50 chromatography were redissolved in 2 ml of medium С (medium С 
contained 0.05 M Tris-HCl buffer pH 7.6, 10-3M DTT and 10-3M EDTA). 
Traces of insoluble material were removed by centrifugation. The supernatant 
fraction was applied onto a column of Sephadex G-100 (2.5 X 100 cm), equili­
brated in medium C. Elution was accomplished with the same medium С at 
a flow rate of 15 ml per hour and fractions of 2.5 ml were collected. 
The elution pattern is visualised in fig. 7. 
A large protein peak devoid of activity emerged from the column at an elution 
volume between 125 and 140 ml. The inhibitor activity peak was located in 
between the two smaller peaks. 
The four most active fractions were combined and tested immediately for 
specific activity, which appeared to be 17,000 units per mg of protein. As 
compared with the active material obtained after DEAE-Sephadex chromato­
graphy the specific activity after gel filtration on Sephadex G-100 had been 
increased about 50 to 60 times. 
In order to obtain high inhibitor activities after gel filtration on Sephadex 
G-100 the introduction of EDTA and reducing agents into the elution buffer 
appeared to be essential, as omittance of these agents caused a gradual decrease 
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in inhibitor activity during this procedure. A complete inactivation was ob­
served after dialysis against distilled water (Chapter VI). 
For further purification all active fractions were combined and the protein 
was precipitated with 70% ammonium sulphate. Activity determinations, 
carried out on the combined eluate, revealed a total inhibitor activity of about 
20,000 units with a specific activity of about 8,000-10,000 units per mg of 
protein. Generally a recovery of about 90% was obtained in this isolation step. 
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FIG. 7. Gel filtration on Sephadex G-100 of the DEAE Sephadex RNase inhibitor fraction. 
Approximately 100 mg of the lyophilised DEAE Sephadex RNase inhibitor fraction was 
applied onto a column of Sephadex G-100 (100 χ 2.5 cm), equilibrated in medium С (consist­
ing of 0.05 M Tris-HCl buffer pH 7.6, lO^M DTT and 10-3M EDTA). 
Elution was performed with medium C. 
Fractions of 2.5 ml were collected. 
absorbance at 280 nm. 
Φ β RNase inhibitor activity (units/ml). 
5.3.6. Chromatography on Enzite-RNase 
The final purification step of the RNase inhibitor was based upon its specific 
property, i.e. RNase inhibition. It is reasonable to assume that inhibition of 
RNase by the protein inhibitor occurs by complex formation, whether it is 
reversible or irreversible. When RNase is covalently bound to an insoluble 
matrix with which a column can be packed, one might expect that, when 
passing through the column, the protein inhibitor is retarded by complex for­
mation. On the other hand interi proteins will not be affected by the polymer-
bound RNase and emerge at the void volume of the column. 
This retardation-chromatography was accomplished by using Enzite-RNase 
- a commercial product - in which bovine pancreatic RNase is covalently 
bound to CM-cellulose according to Mitz and Summaria (1961). 
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Several 70 % ammonium sulphate precipitates of the RNase inhibitor (Se-
phadex G-100 material) were combined and desalted by passage over a column 
of Sephadex G-25 (1 5 X 25 cm), equilibrated m medium D (medium D con­
sisted of 0 05 M sodium phosphate buffer pH 6.0, 10-3M DTT and 10-3M 
EDTA). 
The desalted eluate containing about 40,000 inhibitor units was directly 
applied onto a column of CM-RNase ( 1 0 x 3 5 cm) (1 gram) equilibrated in 
medium D After washing with medium D, inhibitor activity was eluted with 
0 9 M NaCl m medium D A flow rate of as low as 5 ml per hour was main­
tained during the whole chromatographic procedure and fractions of 1 ml were 
collected. 
A typical elution pattern is shown in fig. 8 
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FIG 8 Chromatography on a CM-RNase column of the Sephadex G-100 RNase inhibitor 
fraction 
Several combined 70% ammonium sulphate precipitates of Sephadex G-100 RNase inhi­
bitor fractions (approx 40,000 units) were, after desalting on Sephadex G-25, applied onto 
a column of CM-RNase ( 3 5 x 1 0 cm), equilibrated in medium D (medium D consisted of 
0 05 M sodium phosphate buffer pH 6 0, 10-3M DTT and 10-3M EDTA) 
After washing with medium D, at the arrow elution was performed with 0 9 M NaCl in 
medium D 
Fractions of 1 0 ml were collected 
Of each fraction 10 μΐ was tested in the standard RNase inhibitor assay (Г 6). 
• · absorbance at 280 nm 
χ χ RNase inhibitor activity (percent inhibition). 
Based upon the absorbancy at 280 nm practically all protein emerged at the 
void volume of the column In the fractions obtained after elution with 0 9 M 
NaCl no absorbancy at 280 nm could be detected. However in these fractions 
high inhibitor activity was observed (fig 8). 
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Surprisingly most of the inhibitor activity was found to be present in the 
region of the protein peak, although a slight retardation was observed with 
regard to the inert protein. 
The existence of two different types of RNase inhibitor - as might be deduced 
from the elution pattern - could be excluded. Subjecting the first protein-inhi-
bitor peak to rechromatography on an Enzite-RNase column resulted again in 
a similar distribution of free and bound inhibitor. 
Apparently the column used could only bind approximately 7,000-8,000 
inhibitor units, which was less than theoretically might be expected. Presumably 
a considerable percentage of the total RNase molecules, covalently linked to 
the CM-cellulose, are located at the inner site of the matrix and are not acces-
sable to complex formation with the protein inhibitor molecule. 
As complex formation between RNase and RNase inhibitor was found to 
be dependent on pH (Chapter VI) the chromatographic procedure was also 
carried out at other pH values. However at pH 7.5 no inhibitor could be bound 
onto the RNase column, despite the fact that at this pH maximum complex 
TABLE 4. Purification of RNase inhibitor. 
Starting from the 100,000 g supernatant fraction (approx. 500-600 ml) of 50 rat livers 
(approx. 200 g) the yield of protein and RNase inhibitor units after each purification step 
is given. 
The specific activities were calculated as the amount of RNase inhibitor units per mg of 
protein. 
The percentages of recovery after each purification step were based upon the total amount 
of RNase inhibitor units present in the 100,000 g supernatant fraction. 
Purification step * 
100,000 g super-
natant fraction 
35-65 % ammonium 
sulphate precipitate 
DEAE-Sephadex 
fraction 
Sephadex G-100 
fraction 
Protein 
(mg) 
16,000-18,000 
8,000-10,000 
250-300 
3-6 
Total units 
110,000-140,000 
60,000-90,000 
40,000-60,000 
25,000-50,000 
Specific 
activity 
(units/mg 
protein) 
4.5-6.7 
6.5-7.9 
200-350 
8,000-10,000 
Recovery 
% 
100 
55-65 
30-40 
25-35 
Purifi-
cation 
factor 
1 
1.4 
55 
1800** 
* Enzite chromatography has not been included. 
** Results obtained with pooled inhibitor peak. 
In case that only the top fractions are tested a 3000-4000 fold purification is observed. 
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formation was found in the standard RNase inhibitor assay. Maximal binding 
of the inhibitor onto the polymer-bound RNase was observed at pH 6.0. 
Although about 8,000 inhibitor units were obtained after eluting the Enzite-
RNase column with 0.9 M NaCl, the absorbancy at 280 nm was extremely 
low. Even a sensitive protein determination according to the method of Lowry 
et al. (1951) did not give any reliable results. For this reason a specific activity 
of the RNase inhibitor after this final purification step can not be given at 
present. 
In table 4 the purification of the RNase inhibitor after each step is specified. 
5.4. POLYACRYLAMIDE GEL ELECTROPHORESIS 
After each purification step the protein obtained was analysed by Polyacryl­
amide gel electrophoresis, which was carried out as described in the methods 
section (Chapter IV). 
The patterns obtained are represented in fig. 9. 
It is clear that as compared with the 100,000 g supernatant fraction a number 
of fast-moving components became concentrated after chromatography on 
DEAE-Sephadex, whereas others disappear. After gel filtration on Sephadex 
G-100all slow-moving fractions, still present in the DEAE-Sephadex material, 
were removed whereas the fast-moving bands became more concentrated. 
The protein concentration of the active inhibitor fraction obtained after 
chromatography on Enzite-RNase appeared to be not sufficient to show any 
protein bands on Polyacrylamide gels. The pattern shown in fig. 9 was obtained 
from several combined Enzite-RNase inhibitor preparations, which had been 
concentrated by lyophilization after thorough dialysis against distilled water. 
As compared with the pattern obtained after gel filtration on Sephadex G-lOO 
the RNase inhibitor preparation obtained after chromatography on Enzite-
RNase showed only three main bands on Polyacrylamide gels. What the signi­
ficance might be of this number of protein components in the Enzite-RNase 
inhibitor preparation has to await further investigation. 
5.5. MOLECULAR WEIGHT OF THE RNASE INHIBITOR 
An approximation of the molecular weight of the inhibitor was made with 
the aid of the method of Andrews (1964). This was performed by gel filtration 
of a mixture of cytochrome c, ovalbumin, albumin and a-crystallin together 
with RNase inhibitor on a column of Sephadex G-100 (2.5 χ 100 cm); equili­
brated in medium C. Elution was performed with medium С at a flow rate of 
15 ml per hour. 
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FIG. 9. Polyacrylamide gel electrophoretic patterns of RNcue inhibitor fractions obtained after 
purification step. 
Polyacrylamide gel electrophoresis was performed in 10% gels at pH 8.9, as described in 
chapter IV.3. 
gel 1 : 100,000 g supernatant from rat liver. 
gel 2: 35-65% ammonium sulphate fraction. 
gel 3: DEAE-Sephadex fraction. 
gel 4: Sephadex G-100 fraction. 
gel 5: CM-RNase inhibitor fraction. 
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In fig. 10 the relationship is given between the elution volume and the mole­
cular weight of each protein, including the RNase inhibitor. 
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FIG. 10. Relationship between elution volume and molecular weight of some proteins, including 
RNase inhibitor. 
A mixture of four proteins, with known molecular weight and RNase inhibitor (DEAE-
Sephadex fraction) were applied onto a column of Sephadex G-100 (100 χ 2.5 cm), equilibrated 
in medium C. 
Elution was performed with medium С and fractions of 2.5 ml were collected. 
After measurance of the absorbancy at 280 nm, all fractions were tested for RNase inhibitor 
activity in the standard RNase inhibitor assay (chapter IV.6) and the fraction determined with 
the highest RNase inhibitor activity. 
The relationship between elution volume (Ve) and log molecular weight, was calculated on 
the assumption that the molecular weights of the proteins used are: cytochrome c: 12,400, 
ovalbumin: 45,000, bovine serum albumin: 67,000 and a-crystallin: 800,000. 
The arrow indicates the top of the RNase inhibitor activity peak . 
As the molecular weight of ovalbumin is 45,000 and that of bovine serum 
albumin is 67,000 a molecular weight of the RNase inhibitor of approximately 
50,000 seems to be reasonable. 
5.6. DISCUSSION 
The isolation procedure of the RNase inhibitor described above was used as 
a routine purification method, however a few modifications are possible. 
The use of a 100,000 g supernatant fraction is not essential for the isolation 
of the RNase inhibitor as the whole procedure might well be carried out with 
a 12,000 g supernate as the starting material. A disadvantage of this method 
turned out to be that the specific activity of the protein obtained after chroma­
tography on DEAE-Sephadex was about 50 per cent lower than the activity of 
• cytochrome С 
V ovalbumin 
"inhibitor \^ 
--albumin 
<x-crystallin 
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the protein obtained in our routine procedure. Also after gel filtration on 
Sephadex G-100 the specific activity appeared to be lower. For this reason we 
decided to maintain the 100,000 g centrifugation step in the routine purification 
procedure. 
As was demonstrated in Chapter V.3.4 rechromatography of the protein 
obtained after DEAE-Sephadex chromatography resulted in a two-fold puri-
fication. However the purification achieved by rechromatography was highly 
surpassed by gel filtration on Sephadex G-100. Therefore we omitted the re-
chromatography step in our routine isolation procedure. 
The successful final purification step by chromatography on a CM-RNase co-
lumn proved that the inhibitor actually forms a complex with RNase. This com-
plex formation is strongly dependent on pH and ionic strength as will be demon-
strated in Chapter VI. In our RNase inhibitor assay system we found an optimal 
inhibitor activity at pH 7.0 to 7.8 (6.3). However, when chromatography on 
CM-RNase was carried out at pH 7.8 no inhibitor was bound at all and the 
inhibitor activity was quantitatively recovered in the effluent. At pH 7.0 only 
a small amount of the RNase inhibitor was bound, whereas chromatography 
at pH 6.0 resulted in an optimal binding of the inhibitor onto the column. 
This shift of the optimal pH for complex formation to a lower pH value might 
be caused by a different behaviour of free and polymer-bound RNase. In this 
respect it has to be mentioned that the pH optimum of polymer-bound RNase 
is shifted towards a lower pH value as compared with free RNase. 
In the standard RNase inhibitor assay we observed that no inhibitor activity 
could be detected at high ionic strength (Chapter VI.5.1). This means that at 
high ionic strength no complex formation between RNase and inhibitor occurs. 
We made use of this characteristic to elute the RNase inhibitor from the CM-
RNase column. In order to prevent trailing of RNase inhibitor an eluent with 
0.9 M NaCl was used. 
Summarising it may be concluded that using DEAE-Sephadex chromato-
graphy and gel filtration on Sephadex G-100 a purification of about 3000 times 
could be achieved. This purification could be enhanced by chromatography on 
a CM-RNase column as such a procedure resulted in fractions with extremely 
high inhibitor activities with almost undetectable amounts of protein. 
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CHAPTER VI 
CHARACTERIZATION OF THE RNASE INHIBITOR 
6.1. INTRODUCTION 
Although in 1956 Roth detected the RNase inhibitor in rat liver supernatant 
at present only a limited number of details are known about its characterization. 
Roth (1956) suggested that the inhibitor might be a protein as it appeared 
to be heat-labile and non-dialyzable. More evidence for this suggestion was 
provided by the fact that the inhibitor could be inactivated by sulphydryl 
reactants such as p-chloromercuribenzoate and Pb 2 + ions (Roth 1956, 1958a). 
The inactivation by Pb 2 + ions was partly reversible. Apparently the conclu­
sion that free sulphydryl groups are essential for RNase inhibitor activity 
seemed to be justified. 
In order to verify whether these properties of the RNase inhibitor also applied 
to even more purified fractions we studied the enzyme-inhibitor interaction in 
more detail. The labile character of the inhibitor was also studied. An account 
of these investigations is given in this chapter. 
6.2. TIME DEPENDENCE OF THE RNASE-RNASE INHIBITOR REACTION 
In experiments in which the effect of the sequence of the addition of enzyme, 
substrate and inhibitor was studied we found that addition of RNA to the 
enzyme prior to the addition of inhibitor had no influence on the extent of 
τ 1 1 1 г 
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FIG. 11. Kinetics of the RNase reaction in the absence and presence of RNase inhibitor. 
The incubation conditions were as described in chapter IV.6. One unit RNase inhibitor 
(DEAE-Sephadex material) was added at time zero and the reaction stopped after different 
time intervals. 
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RNase-RNase inhibitor complex formation In the routine assay procedure 
RNase inhibitor was added to RNase prior to the addition of RNA. 
We determined the time dependence of the RNase reaction in the absence 
and presence of a constant amount of RNase inhibitor The incubation mixture 
contained the components as described in the methods section (Chapter IV 6). 
The amount of the RNase inhibitor (DEAE-Sephadex fraction) was added 
which caused 50 percent inhibition 
As can be seen in fig 11 the inhibition was 50 % directly after the reaction 
was started and the same percentage was found at each incubation time It 
might be concluded that the complex formation between RNase and RNase 
inhibitor occurred directly and was maintained during the whole reaction period. 
6 3. PH OPTIMUM 
Bovine pancreatic ribonuclease has a pH optimum of about 7.7-8 2 (see 
chapter III) It is well-known that its activity is strongly dependent on 
ionic strength (Roth, 1958a, Anfmsen and White, 1961) 
For this reason we determined the pH optimum curve of RNase activity m 
Tris-HCl buffer of a constant ionic strength of 0 083 Moreover we determined 
the percentage of inhibition caused by a constant amount of RNase inhibitor 
(DEAE-Sephadex fraction) at each respective pH. 
The results are shown in fig 12. 
100 
"З" 80 
ν ' 
f 60 
υ 
Ό 
αι 40 
to 
Я 
Ζ 
•* 20 
70 ао 90 
pH ( in incubation mixture) 
FIG. 12 pH optimum curve of RNase and RNase inhibitor activity 
Incubation was performed in Tris-HCl buffer with constant ionic strength (0 083) The 
further incubation conditions were as described in chapter IV 6 
The RNase inhibitor activity (DEAE-Sephadex material) was calculated as the percentage 
of inhibition of the residual RNase activity at each p H . 
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In the range of 7.0 to 8.0 the percentage of inhibition was nearly constant. 
However, above pH 8.0 it decreased drastically. This might be caused by the 
fact that the RNase inhibitor is rather unstable above pH 8.0 (see chapter VI.7). 
As at pH 7.8 the RNase activity was optimal and the extent of inhibition 
reached the highest value, the RNase-RNase inhibitor assay was routinely 
carried out at pH 7.8 in Tris-HCl buffer with the same ionic strength of 0.083 
as was used in this experiment. 
6.4. EFFECT OF I N C R E A S I N G AMOUNTS OF RNASE I N H I B I T O R ON 
RNASE ACTIVITY 
In order to study whether increasing amounts of RNase inhibitor propor­
tionally diminished RNase activity we determined the percentage of inhibition 
caused by varying the amounts of RNase inhibitor added to the incubation mixture. 
In fig. 13 the correlation between the units of RNase inhibitor added and 
the percentage of inhibition is given. 
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FIG. 13. Correlation between percentage of inhibition and amount of RNase inhibitor added. 
The incubation conditions were as described in chapter IV.6. One unit of RNase inhibitor 
activity is defined as that amount which causes 50% inhibition. 
From the DEAE-Sephadex material used here 1 unit corresponded with 3.5 μg of protein. 
As was mentioned in chapter IV.6 one unit of inhibitor activity is defined 
as that amount which causes 50% inhibition of 0.005 μg RNase under standard 
conditions. When DEAE-Sephadex material was used 1 unit of inhibitor activity 
corresponded with 3.5 μg of protein. Similar curves were obtained with more 
purified RNase inhibitor after gel filtration on Sephadex G-100. 
A linear relationship was observed between zero and 1.5 inhibitor units. 
However, above this amount the percentage of inhibition was not proportional 
\ V.: 
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to the amount of inhibitor added. To determine the amount of inhibitor added 
in the routine procedure we always took care that the percentage of inhibition 
never exceeded 75 percent. 
A striking feature in fig. 13 is the observation that a 100 percent inhibition 
level could not be reached. The RNase activity could only be suppressed 
completely by the addition of very high concentrations of inhibitor. 
A similar effect was found by Roth (1956) and Shortman (1961). Whether this 
rest activity was due to a contaminant in the pancreatic RNase preparation, 
which was not inhibited by the RNase inhibitor, can not be excluded. 
6.5. EFFECT OF DIFFERENT IONS ON THE RNASE-RNASE 
INHIBITOR REACTION 
6.5.1. Effect of sodium chloride 
As was pointed out in chapter VI.3 the RNase activity is strongly dependent 
on the ionic strength. To find out whether the ionic strength also affected the 
RNase-RNase inhibitor interaction we determined the effect of increasing 
amounts of sodium chloride added to the standard incubation mixture. The 
RNase inhibitor used was a DEAE-Sephadex fraction. 
The results are shown in fig. 14. 
M NaCI ( in incubation mixture) 
FIG. 14. Dependence of RNase and RNase inhibitor activity on NaCl concentration. 
The incubation conditions were as described in chapter IV.6. 
The NaCI concentrations given were the final concentrations in the incubation mixtures. 
RNase inhibitor (DEAE-Sephadex material) concentration was 0.75 unit per incubation 
mixture. 
The addition of increasing amounts of NaCl to the standard incubation 
mixture with an ionic strength of 0.083 resulted in a gradual decrease of the 
RNase activity. In the meantime increasing ionic strength affected the 
RNase-RNase inhibitor complex formation up to the addition of 0.15 M NaCl. 
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As a consequence the percentage of inhibition (being the difference between 
RNase activity whithout and whith inhibitor) decreased to zero above 0.15 M 
NaCl. 
6.5.2. Effect of Magnesium ions 
In chapter III the inhibitory effect of metal ions on bovine pancreatic RNase 
was discussed. We therefore studied the effect of Mg 2 + ions on the RNase and 
RNase inhibitor activity. Varying amounts of MgCU were added to the stand­
ard incubation mixture. The RNase activity was determined in the absence 
and presence of RNase inhibitor (DEAE-Sephadex material). 
The results are shown in fig. 15. 
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FIG. 15. Dependence of RNase and RNase inhibitor activity on the Mg2+ concentration. 
The incubation conditions were as described in chapter IV.6. 
The Mg2+ concentrations given were the final concentrations in the incubation mixtures. 
RNase inhibitor (DEAE-Sephadex material concentration was 0.75 unit per incubation 
mixture. 
It is clear that Mg 2 + ions in all concentrations drastically reduce the RNase 
activity. As a consequence the percentage of inhibition caused by the RNase 
inhibitor was reduced to nearly undetectable values. On the other hand the 
highest inhibition values were observed when Mg 2 + ions were omitted. There­
fore it is important to be sure that no Mg 2 + or other metal ion contaminants 
are introduced into the incubation mixture. 
6.5.3. Effect ofEDTA 
As metal ions strongly reduce bovine pancreatic RNase activity we studied 
the effect of EDTA. Increasing amounts of EDTA were added to the standard 
59 
incubation mixture and the RNase activity was tested in the absence and pre· 
sence of RNase inhibitor (DEAE-Sephadex material). 
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FIG. 16. Dependence of RNase and RNase inhibitor activity on the EDTA concentration. 
The incubation conditions were as described in chapter IV.6. 
The EDTA concentrations given were the final concentrations in the incubation mixtures. 
RNase inhibitor (DEAE-Sephadex material) concentration was 0.75 unit per incubation 
mixture. 
As can be seen in figure 16 the addition of EDTA to the incubation mixture 
had any effect neither on the RNase activity nor on the RNase inhibitor activity. 
For this reason extra addition of EDTA to the incubation mixture of the 
standard RNase inhibitor assay was not necessary. However, to prevent any 
introduction of metal ions to the incubation mixture 10~3M EDTA was used 
in all buffers during the isolation of the RNase inhibitor. 
6.6. PROTEIN CHARACTER OF THE RNASE INHIBITOR 
On account of its observed heat-lability and inactivation by sulphydryl reac-
tants Roth (1956, 1958a) suggested that the RNase inhibitor might be a protein. 
Evidence for this suggestion was provided by Shortman (1962) who demon­
strated an inactivation of the RNase inhibitor by trypsin and papain. 
We confirmed the inactivation by trypsin and observed the same effect by 
pronase treatment. 
6.6.1. Effect of trypsin on the RNase inhibitor activity 
In order to inactivate the RNase inhibitor about 5.0 RNase inhibitor units 
(DEAE-Sephadex material) were preincubated in the presence and absence of 
10 μg trypsin in Tris-HCl buffer at pH 7.8. For comparison 10 μg trypsin were 
preincubated under identical conditions. 
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After a preincubation period of 20 min. at 25° С samples of the preincubation 
mixtures corresponding to about 1 unit of RNase inhibitor were added to the 
standard incubation mixture and tested for their residual inhibitor activity. 
Preincubation of 1.0 unit of RNase inhibitor did not diminish its inhibitory 
activity as 61 % inhibition corresponding to 1.25 units, was recovered. On the 
other hand incubation with trypsin resulted in a complete inactivation of the 
inhibitor, whereas trypsin alone did not reveal any effect on the RNase activity. 
These results are summarized in table 5. 
TABLE 5. Effect of trypsin on RNase inhibitor activity. 
About 5.0 RNase inhibitor units (DEAE-Sephadex fraction) were preincubated at 250C 
for 20 minutes in 0.4 ml of 0.025 M Tris-HCl buffer pH 7.8 in the presence and absence of 
10 \ig trypsin. 
After preincubation samples (0.1 ml) of the preincubation mixtures were tested for residual 
RNase inhibitor activity in the standard incubation mixture (chapter IV.6). 
For comparison the effect of preincubated trypsin on RNase activity was also tested. 
Preincubation mixture RNase inhibition (%) 
RNase inhibitor + trypsin 0 
RNase inhibitor 61 
Trypsin 0 
6.6.2. Effect of pronase on the RNase inhibitor activity 
RNase inhibitor (5.0 units of DEAE-Sephadex material) was also preincubated 
in the absence and presence of 40 μ§ pronase in 0.025 M Tris-HCl buffer pH 7.8 
+ 0.001 M CaCh. After preincubation for 30 minutes at 25° С samples corres­
ponding to about 1 RNase inhibitor unit were tested for their residual RNase 
inhibitor activity. 
The results are shown in table 6. 
TABLE 6. Effect of pronase on RNase inhibitor activity. 
About 5.0 RNase inhibitor units (DEAE-Sephadex fraction) were preincubated at 250C 
for 30 minutes in 0.4 ml of 0.025 M Tris-HCl buffer containing 0.001 M СаСЬ in the absence 
and presence of 40 μg pronase. 
After preincubation samples (0.1 ml) of the preincubation mixtures were tested for residual 
RNase inhibitor activity in the standard incubation mixture (Chapter IV.6). 
For comparison the effect of preincubated pronase on RNase activity was also tested. 
Preincubation mixture RNase inhibition (%) 
RNase inhibitor + pronase 0 
RNase inhibitor 54 
Pronase 0 
61 
Once again it is clearly demonstrated that the RNase inhibitor could be 
completely destroyed by pronase, whereas pronase alone did not affect the 
RNase activity at all. 
6.7. STABILITY OF THE RNASE INHIBITOR 
The ribonuclease inhibitor was unstable after gel filtration on Sephadex 
G-100. Ninety percent of inactivation was observed when the Sephadex G-100 
material was dialysed and lyophilised. On the other hand lyophilised 
DEAE-Sephadcx material could be stored for months at —20°С without loss 
of any activity. 
Several attempts, i.e. storage at 0°, freezing at —20°, freezing or lyophili-
zation in the presence of 10% dextrane, to preserve the activity of the RNase 
inhibitor after gel filtration on Sephadex G-100 were unsuccessful. Preservation 
of the purified RNase inhibitor could only be achieved by precipitation of the 
protein at 70% ammonium sulphate saturation and storage at —20°С 
The ammonium sulphate was removed from the Sephadex G-100 preparation 
before use by gel filtration on a Sephadex G-25 column (1.5 χ 20 cm). 
6.7.1. Effect of temperature on RNase inhibitor activity 
RNase inhibitor (Sephadex G-100 material) was preincubated at different 
temperatures in 0.05 M sodium phosphate buffer at pH 6.0 and pH 8.0. In 
both cases the preincubation was performed in the presence and absence of 
10-3M DTT. 
After preincubation for 30 min. samples of the preincubation mixtures were 
tested for their RNase inhibitor activity in the standard assay procedure. 
The results are shown in fig. 17. 
In the presence of DTT the curves at both pH values were identical and 
inactivation only occurred when preincubation was performed above 37°C. In 
the absence of DTT at pH 6.0 only a slight decrease of the inhibitor activity 
was observed at temperatures between 0° and 37° C. However, when DTT was 
omitted at higher pH values (pH 8.0) an almost complete inactivation occurred 
already during preincubation at 0°. At higher temperatures no residual activity 
could be detected at all. 
From these results it may be concluded that DTT has a stabilizing effect on 
the RNase inhibitor activity. When no reducing agent was present the RNase 
inhibitor activity could be fairly well maintained at lower pH values. 
Apparently free thiol groups are essential for the inhibitor activity, which is 
in agreement with the inactivation by PCM В as observed by Roth (1956,1958a). 
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FIG 17 Effect of preincubation on the RNase inhibitor activity at different temperatures 
Preincubation of the RNase inhibitor (Sephadex G-100 material) was performed for 30 mm 
in 0 05 M sodium phosphate buffer pH 6 0 and 8 0 in the absence and presence of ΙΟ- 3 M DTT 
After preincubation samples of the preincubation mixtures were tested for residual RNase 
inhibitor activity in the standard incubation mixture (described in chapter IV 6). 
• · p H 6 0 + I O - 3 M ο π ­
ό о pH 6 0 — DTT 
А Δ pH 8 0 + Ю-
3
 M DTT 
Δ д pH 8 0 —DTT 
6 7 2. Effect of pH on the RNase inhibitor activity 
In view of the lability at high pH we investigated the effect of different pH 
on the stability of the RNase inhibitor 
RNase inhibitor (Sephadex G-100 fraction) was preincubated at 37° in 0 05 M 
sodium phosphate buffer of different pH values The preincubation was per­
formed in the presence and absence of 10_ 2M DTT and 10~2M EDTA 
After preincubation for 30 or 60 mm samples of the preincubation mixtures, 
containing approximately one unit of RNase inhibitor were tested for their 
residual RNase inhibitor activity 
The results are shown in fig 18 
When DTT and EDTA were omitted an incubation period of 30 mm. at 37° 
resulted in a marked decrease of the RNase inhibitor activity at pH values 
above pH 6 0. When preincubation was prolonged till 60 mm. the RNase 
inhibitor was inactivated at all pH's tested 
However, when preincubation was performed in the presence of 10~2M DTT 
and 10_ 2M EDTA even 60 mm preincubation at 37° did not cause any loss 
of activity at any of the pH's tested 
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Reactivation of the inactivated RNase inhibitor by re-addition of DTT and 
EDTA after preincubation could not be accomplished either by varying the 
pH values or by adding more DTT up to a concentration of 0.1 M. 
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FIG. 18. Effect of preincubation on the RNase inhibitor activity at different pH. 
Preincubation of the RNase inhibitor (Sephadex G-100 material) was performed in 0.05 M 
sodium phosphate buffer for 60 mm in the presence of 10~2M DTT and 10~2M EDTA and 
for 30 and 60 min without DTT and EDTA. 
After preincubation samples of the preincubation mixtures were tested for residual RNase 
inhibitor activity in the standard incubation mixture (described in chapter IV.6). 
• · 60 min + 10-2M DTT -t- 10-2M EDTA. 
о о 30 min — DTT — EDTA. 
• • 60 min — DTT — EDTA. 
6.8. S P E C I F I C I T Y OF THE RNASE I N H I B I T O R 
The presence of a DNase inhibitor was demonstrated in human urine 
(Kowlessar et al., 1957) and Bacillus subtilis (Strauss and Marone, 1967). A 
partial purification of a DNase inhibitor from rat serum was obtained by Berger 
and May (1967). The presence of a DNase inhibitor in rat liver supernatant 
was reported by Zalite and Roth (1964). 
To examine whether purified RNase inhibitor might be contaminated with 
some DNase inhibitor activity we tested the purified RNase inhibitor (DEAE-
Sephadex fraction) for inhibition activity against DNase. The DNase inhibitor 
assay of Zalite and Roth (1964) as described in the methods section (chapter 
1V.7), was used. 
As can be concluded from table 7 no DNase inhibition was found in the 
RNase inhibitor preparation up to 200 μg. On the contrary even slightly higher 
absorbancy values were obtained as compared with DNase alone. This might 
erroneously be interpreted as DNase contamination of the inhibitor. 
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TABLE 7. Effect of RNase inhibitor on DNase activity. 
The effect on DNase activity of 200 and 40 pg RNase inhibitor (DEAE-Sephadex fraction) 
was compared with that of 200 and 40 μβ of bovine serum albumin. 
The DNase activity was assayed according to the method of Zalite and Roth (1964) as 
described in chapter IV.7. 
RNase inhibitor Albumin DNase Absorbance at 260 nm 
- + 0.473 
40 pg + 0.555 
200 Mg + 0.585 
40 Mg - + 0.552 
200 Mg - + 0.598 
- — 0.073 
However, the same effect was observed with corresponding amounts of al­
bumin. Therefore this phenomenon is merely a protein effect. 
An amount of about 3 μ£ of RNase inhibitor protein exhibits 50% inhibition 
of RNase, whereas 200 pg protein did not reveal any activity against DNase. 
Therefore it is reasonable to assume that the RNase inhibitor acts specifically 
on RNase. 
6.9. DISCUSSION 
As was pointed out in chapter III.4 many factors are known which affect 
bovine pancreatic ribonuclease activity. Among these are certain polyanions, 
both naturally occurring such as bentonite and heparin and synthetic ones like 
polyvinyl sulphate. Polycations like protamine, polylysine, spermidine and sper­
mine also inhibit pancreatic RNase. Other categories are metal ions and 
mononucleotides which both have inhibitory effects. However most naturally 
occurring RNase inhibitors such as those isolated from Bacillus subtilis and 
animal organs have a protein character. The RNase inhibitor from rat liver 
belongs to this last category and has been proved to be a protein. 
This protein acts specifically on RNase as was shown in our DNase experi­
ments (chapter VI.8). Therefore the RNase-RNase inhibitor interaction seems 
to be a specific interaction. 
The complex between RNase and RNase inhibitor is formed instanteneously 
(chapter VI.2) and is strongly dependent on pH (6.3) and ionic strength (6.5), 
whereas Mg 2 + ions probably only inhibit the RNase activity but do not affect 
the enzyme-inhibitor complex formation. 
An important feature is the role of free -SH groups in RNase inhibitor acti­
vity. This statement is not only based on the inhibition with PCMB (Roth, 1956, 
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1958a) but also on the influence of DTT on the stability of the RNase inhibitor 
as was described in this chapter (6.7). Which function the free-SH groups have 
in the formation of the RNase-RNase inhibitor complex can not be answered 
yet. Whether the -SH group is responsible for the formation of the enzyme-
inhibitor complex or specifically interacts with an essential amino acid in the 
active centre of RNase after complex formation is terminated has to be esta-
blished. As was mentioned in chapter III.2.2 the histidyl residues (12 and 119) 
and lysine (41) are located in or near the active centre of bovine pancreatic 
RNase. The interaction of one of the -SH groups of the inhibitor with one of 
the amino acid residues mentioned above might be possible. 
The crucial observation for the isolation and further kinetic studies of the 
inhibitor is the stabilizing effect of DTT and EDTA (6.7). This property en-
hances the usefulness of the RNase inhibitor which is now available in a highly 
purified state. 
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CHAPTER VII 
EFFECT OF RNASE INHIBITOR ON POLYRIBOSOMES 
7.1. INTRODUCTION 
Bont et al. (1965) first described a stabilizing effect of the 100,000 g super­
natant fraction of rat liver on the structural integrity of rat liver polyribosomes. 
These authors suggested that the active factor might be identical with the RNase 
inhibitor detected by Roth (1956) in rat liver supernatant. This suggestion was 
supported by the observation that the breakdown of rat liver polyribosomes 
by bovine pancreatic RNase could be counteracted by the addition of rat liver 
supernatant. 
Since then the usefulness of the rat liver RNase inhibitor during the isolation 
of polysomes has been confirmed by several authors. 
Blobel and Potter (1966) demonstrated that inactivation of the rat liver RNase 
inhibitor by heat or by sulphydryl reactants resulted in rat liver polysome break­
down. Moreover, they observed that the sedimentation profiles were strongly 
affected by the RNase-RNase inhibitor relationship during cell fractionation. 
Rat liver polyribosomes prepared from the microsomal pellet by treatment 
with sodium deoxycholate were deficient in polyribosomes and contained pri­
marily ribosome dimers (Lawford, Langford and Schachter, 1966). However, 
dimer formation could be prevented and a good polyribosome pattern obtained 
from that fraction provided treatment with DOC was carried out in the pre­
sence of rat liver supernatant. The protective effect of the RNase inhibitor on 
liver polysomes could be eliminated by pretreatment of the inhibitor with 
4 χ 10 _ 4M parachloromercuribenzoate by which the RNase inhibitor is known 
to be inactivated (Lawford and Schachter, 1967). 
Rat liver RNase inhibitor has also been successfully used in the preparation 
of polyribosome-like particles from rat liver nuclei (Lawford et al., 1966, 1967). 
The addition of RNase inhibitor during the isolation of rat liver polysomes 
resulted not only in higher yields of polyribosomes but also in better and more 
reproducible sedimentation profiles as well as an increased ability to incorporate 
amino acids (Sugano et al., 1967). 
Polyribosomes isolated from regenerating rat liver after partial hepatectomy 
appeared to be more stable than polyribosomes derived from normal liver. The 
structural stability of the former was even preserved after incubation without 
supernatant (Bont et al., 1967). Whether this higher stability might be caused by 
the fact that these particles contained more RNase inhibitor or that they were less 
67 
contaminated with ribonudease as compared with polyribosomes from normal 
rat liver, due to a lower RNase concentration in regenerating liver remains an 
open question. 
The RNase inhibitor is not organ-specific as was demonstrated by Northup 
et al. (1967) who found an inhibitory effect of rat liver supernatant on rat spleen 
RNase and also a protective effect on spleen polyribosomes against breakdown. 
A similar protective effect was observed on polyribosomes from rat bone mar-
row (Minguell and Peretta, 1967; Grau and Flavelukes, 1968) and from rat 
cerebral cortex (Takahashi et al., 1966). 
The action of rat liver RNase inhibitor does not seem to be species-specific. 
The amino acid incorporating ability of polyribosomes prepared from organs 
from different animal sources could be increased by the use of RNase inhibitor 
from rat liver. Its protecting effect was demonstrated on polysomes from sheep 
thyroid gland (Cartouzou et al., 1967), from chicken liver (Siler and Fried, 1968) 
and from bovine anterior pituitary gland (Gospodarowicz and Laporte, 1968). 
The existence of an RNase inhibitor is not only restricted to rat liver. Pro-
tection of polysomes from rat cerebral cortex against breakdown could also be 
achieved by the use of an RNase inhibitor prepared from pig cerebral cortex 
(Takahashi et al., 1966). Bloemendal et al. (1966) were able to show that super-
natant from either normal or transplanted mouse pituitaries protected rat liver 
polysomes against breakdown. The 100,000 g supernatant of bovine anterior 
pituitary gland also contains an RNase inhibitor similar to that of rat 
liver (Gospodarowicz and Laporte, 1968). 
Another important discovery was made by Stahl et al. (1968) who demon-
strated that rat liver polysomes could only be reformed from ribosomal sub-
units by re-addition of Mg2+ ions provided rat liver cell sap was present during 
the dissociation of the ribosomes into their subunits in the presence of EDTA. 
Experiments with pulse-labelled RNA supported the view that after treatment 
of the polyribosomes with EDTA in the presence of rat liver cell sap messenger 
RNA remains with the subunits. Similar results were obtained by Nolan and 
Arnstein (1968) with reticulocyte polyribosomes. 
All authors mentioned above suggested that the protective effect of rat liver 
supernatant on polyribosomes might be the result of RNase inhibition. 
In this chapter stronger evidence will be provided in order to confirm this 
suggestion. 
7.2. STABILIZATION OF RAT LIVER POLYRIBOSOMES 
When rat liver polyribosomes, prepared as described in the Methods section, 
were incubated in the absence of rat liver supernatant they were dissociated 
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into 80 S particles. However, this breakdown did not occur when incubation 
was performed in the presence of rat liver supernatant. This could be demon­
strated clearly by sucrose-density centrifugation. 
The patterns are shown in figure 19. 
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mo. 19. Stabilization of rat liver polyribosomes by RNase inhibitor during incubation. 
Rat liver polyribosomes (800 \i% RNA), prepared as described in chapter IV.2, were incubat­
ed for 30 minutes at 37° С in the absence and presence of RNase inhibitor fractions. 
The amounts of protein added per 200 pg polysomal RNA were: 32 \i% of the 100,000 g 
supernatant fraction; 0.97 ug of a DEAE-Sephadex fraction or 0.011 μg of a Sephadex G-100 
fraction. 
For comparison 800 μg of polyribosomes were incubated at 0° for 30 min. 
After incubation the mixtures were carefully layered on top of linear (10-30%) sucrose 
density gradients. Centrifugation, collection of the fractions and the measurance of the 
absorbancy at 260 nm was performed as described in chapter IV.4. 
• · polyribosomes incubated at 0° for 30 min. 
о о polyribosomes incubated at 37° for 30 min. 
χ χ polyribosomes incubated at 37° for 30 min. 
in the presence of different RNase inhibitor fractions. 
The arrow indicates direction of sedimentation. 
The incubation mixture consisted of: 
polyribosomes (800 μ£ RNA), 0.008 M MgCh, 0.025 M KCl, 0.05 M Tris-HCl 
buffer pH 7.6. The final volume was 1 ml and incubation was carried out for 
30 min at 37°. After incubation the mixtures were carefully layered on top of 
a linear (10-30%) sucrose density gradient. For comparison polyribosomes 
(800 μg RNA) kept at 0° were directly loaded onto the gradient. Centrifugation, 
collection of the fractions and measurement of the absorbance at 260 nm was 
performed as described in the Methods section (chapter IV.4). 
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In figure 19 the profile of the untreated polysomes is shown. The polysomes 
incubated without 100,000 g supernatant are completely broken down whereas 
in the presence of 100,000 g supernatant only a small shift towards the 80 S 
region could be observed. 
Exactly the same pattern was found when the incubation was carried out in 
the presence of the more purified fractions derived by DEAE-Sephadex chro­
matography or by gel filtration on Sephadex G-100. 
In order to verify whether purification of the RNase inhibitor, described in 
chapter V, was parallelled by a purification of the polysome stabilizing factor, 
the stabilizing activity of each fraction was determined. Therefore polyribo­
somes were incubated with varying amounts of protein after each purification 
step and the incubation mixtures were analyzed by sucrose gradient centrifu-
gation. 
The minimal amounts of protein which were able to protect rat liver polysomes 
(200 μg RNA) against breakdown are given in table 8. 
TABLE 8. The minimal amounts of RNase inhibitor fractions capable to preserve rat liver po­
lyribosomes. 
Rat liver polyribosomes were incubated in the presence of varying amounts of protein of 
cacli RNase inhibitor fraction. 
The minimal amounts of protein which were capable to keep the polyribosomes (200 μg 
RNA) intact as judged on sucrose density gradients are given. 
RNase inhibitor fraction protein ^ g ) 
100,000 g supernatant 32 
DEAE-Sephadex 0.97 
Sephadex G-100 0.011 
Lower amounts ofthe supernatant and of the purified fractions could only par­
tially prevent breakdown of the polyribosomes. 
From these data it might be concluded that after gel filtration on Sephadex 
G-100 not only the RNase inhibitor but also the polysome stabilizing fractor 
has been purified by about 3,000 times. 
This observation provides strong evidence that the polysome stabilizing factor 
is identical with the RNase inhibitor. 
7.3. EFFECT OF RNASE INHIBITOR ON THE AMINO ACID 
I N C O R P O R A T I N G ABILITY OF RAT LIVER POLYRIBOSOMES 
If rat liver polyribosomes, preincubated in the presence of RNase inhibitor 
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are effectively protected against breakdown this should be reflected in the pre­
servation of their amino incorporating ability. 
Rat liver polyribosomes were preincubated in the absence and presence of 
varying amounts of RNase inhibitor fractions. The product of each purification 
step was tested. A similar procedure was carried out as described in VII.2 
though the preservation of the integrity of the polysomes was tested for their 
amino acid incorporating ability in stead of by sucrose density gradient analysis. 
Preincubation of the polysomes (1600 μg) was carried out as described in 
VII.2 but in a final volume of 600 μΐ. 
After preincubation during 30 min at 37° two samples (75 μΐ) of each pre­
incubation mixture, containing 200 μg polysomal RNA were tested for their 
amino acid incorporating ability. 
Amino acid incorporation and measurance of the radioactivity was performed 
as described in the Methods section (chapter IV.5). 
The results are shown in table 9. 
TABLE 9. 14C-leucine incorporation activity of rat liver polyribosomes. 
Rat liver polyribosomes (1600 μg RNA) were preincubated in the absence and presence 
of varying amounts of protein of each RNase inhibitor fraction. 
After preincubation samples (75 μΐ, 200 pg RNA) of the mixtures were tested for residual 
l4C-leucine incorporation activity. 
Incubation was performed as described in chapter IV.5. 
Preincu­
bation 
+ 
+ 
+ 
+ 
RNase inhibitor 
fraction added 
_ 
-
100,000 g super­
natant fraction 
DEAE-Sephadex 
fraction 
Sephadex G-100 
fraction 
Protein added 
per 200 \ІЪ 
RNA (Mg) 
_ 
-
32 
0.97 
0.011 
RNase inbitor 
added per 200 pg 
RNA (units) 
_ 
-
0.16 
0.28 
0.099 
Counts/minute 
per 200 Mg RNA 
5318 
2215 
4191 
4922 
4850 
Addition of the minimal amounts of protein which were able to keep the 
polysomes intact as found from sucrose density gradients resulted in maxi­
mal incorporation results. Addition of higher amounts merely resulted in the 
same incorporation values whereas lower amounts gave only intermediate in­
corporation activities. 
From these data it seemed justifiable to assume that the protective effect of 
RNase inhibitor on polyribosomes against breakdown is accompanied by the 
preservation of their amino acid incorporating ability. 
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A striking feature of these results is the observation that more RNase inhi­
bitor units of the DEAE-Sephadex material and of the 100,000 g supernatant 
were necessary to preserve the polysomal integrity as compared with the Se-
phadex G-100 fraction. 
A similar inhibitory effect of the DEAE-Sephadex fraction was observed by 
Konings (1969) on the amino acid incorporation directed by rat liver RNA in 
the Escherichia coli cell-free system. 
We supposed that this might be caused by some factor having an inhibitory 
effect on the amino acid incorporation. This factor might be present in the 
100,000 g supernatant fraction and presumably became concentrated after DEAE-
Sephadex chromatography but was eliminated by gel filtration on Sephadex 
G-100. This phenomenon will be further discussed in the next part of this chapter. 
7.4. EFFECT OF RNASE INHIBITOR ON THE AMINO ACID 
INCORPORATION OF CALF LENS POLYRIBOSOMES 
In chapter VII.3 we described the presence of some factor in the rat liver 
supernatant which inhibits the amino acid incorporation. This inhibitory effect 
was not only restricted to rat liver polyribosomes as we were able to demonstrate 
a similar behaviour on polyribosomes from calf lens. 
The endogenous 14C-leucine incorporating activity of calf lens polyribosomes 
was tested in the presence (and absence) of several protein fractions obtained 
during the purification of the RNase inhibitor. 
Calf lens polyribosomes were isolated as described in the Methods section 
(chapter IV.2). The incubation mixture was the same as described for rat liver 
polysomes (chapter IV.5) except that rat liver polysomes were replaced by calf 
lens polysomes. Calf lens instead of rat liver cell sap was used as an enzyme 
source. After addition of 25 μΐ of each protein fraction to the incubation 
mixture (225 μΐ) at zero time, the mixtures were incubated for differenttime inter­
vals at 37°. In the control experiment 25 μΐ buffer was added at zero time. The 
reaction was stopped with TCA. The mixtures were poured onto Millipore 
filters and radioactivity was measured as described in chapter IV.5. 
The 14C-leucine incorporation by calf lens polyribosomes in the presence of 
different protein fractions in shown in figure 20. 
The inhibitory action of the DEAE-Sephadex fraction on the amino acid 
incorporation activity of calf lens polyribosomes is clearly shown, whereas 
neither the RNase inhibitor fraction from the Sephadex G-100 column nor the 
preceeding protein peak did reveal any such activity. On the other hand the 
protein peak migrating in front of it obtained after gel filtration on Sephadex 
G-100 (fig. 7) also exhibited inhibitory activity on the amino acid incorporation. 
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It was beyond the scope of this thesis to further investigate in more detail 
what kind of factor might be responsible for the inhibition of the amino acid 
incorporation. Possibly it might be caused by the action of an exonuclease 
present in rat liver cell sap as was demonstrated by Hunter and Körner (1968, 
1969). 
However, from the foregoing experiments it may be concluded that the inhi-
bition of the amino acid incorporation is not caused by the action of the 
ribonuclease inhibitor. 
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Fio. 20. uC-leucine incorporation activity of calf lens polyribosomes in the presence of different 
protein fractions. 
Calf lens polyribosomes (100 pg RNA) were incubated during different time intervals with 
calf lens supernatant (2 mg of protein). The incubation mixtures (225 μΐ) contained the com­
ponents as described for rat liver polyribosomes in chapter IV.5. 
At time zero 25 μΐ of the following fractions were added: 
χ χ 25 μΐ buffer; 
• · 25 μΐ Sephadex G-100 RNase inhibitor fraction (11 μg of protein, 102 units); 
Δ - . - . - . - . Δ 25 μΐ Sephadex G-100 first protein peak (328 μg of protein); 
о о 25 μΐ Sephadex G-100 second protein peak (328 μg of protein); 
• - . . - . . - D 25 μΐ DEAE-Sephadex RNase inhibitor fraction (410 μg of protein, 102 units). 
After different time intervals the reaction was stopped by the addition of TCA. 
The mixtures were poured onto millipore filters and radioactivity was measured as described 
in chapter IV.5. 
7.5. THE EFFECT OF RNASE INHIBITOR ON RIBISOMAL SUBUNITS 
Bacterial ribosomes can be dissociated into their subunits by low concentra­
tions of Mg 2 + ions (Tissières et al., 1959). On the other hand when liver poly-
somes are dissociated at low Mg2+ concentrations, even as low as 1 μΜ, only 
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a marked conversion into monomeric ribosomes could be observed (Munro et 
al., 1964). A further dissociation into ribosomal subunits was obtained by the 
addition of EDTA to the suspending medium (Hamilton and Petermann, 1959; 
Tashiro and Siekevitz, 1965). 
Reconstitution of bacterial ribosomes active in protein synthesis from their 
subunits by re-addition of Mg 2 + ions was demonstrated by Staehelin and Mesel-
son (1966). However, Tashiro and Siekevitz (1966) failed to reconstitute guinea 
pig liver ribosomes under similar conditions. 
Stahl et al. (1968) demonstrated that rat liver ribosomes and polysomes active 
in incorporation of amino acids could only be reformed from ribosomal sub-
units provided cell sap was present during the dissociation of the ribosomes. 
However, addition of cell sap after completion of the dissociation by EDTA 
was not sufficient. Experiments with pulse-labelled RNA support the view that 
messenger RNA remains with the particles after treatment with EDTA in the 
presence of cell sap as also was shown in reticulocyte ribosomes (Nolan and 
Arnstein, 1968). 
It is often hardly possible to reconstitute ribosomes from their subunits as 
the small subunits appear to be very sensitive to the action of RNase (Fenwick, 
1968; Marbaix and Burny, 1964). If RNase is present during the dissociation 
the small subunit might be completely broken down, whereas the large subunit 
is more resistant towards the action of RNase. 
We observed this effect during preparation of ribosomal subunits from calf 
lens polysomes. When the dissociation was performed at a concentration of 
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FIG. 21. Effect of RNase inhibitor on the stability of ribosomal subunits of calf lens during 
dissociation with EDTA. 
Calf lens polyribosomes (32 μg RNA) were dissociated in 1 ml buffer containing 6.4 mmoles 
EDTA and 2.5 mmoles Mg2 '. The arrow indicates the direction of migration. 
Ultraviolet recordings at 30.460 rev./min., 18 min after reaching maximum speed. 
RNase inhibitor absent. 
RNase inhibitor (DEAE-Sephadex fraction; 100 μg of protein, 24 units) present. 
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lar£e subunits 
0.025 M magnesium in the presence of EDTA and RNase was present in the 
polysomal preparation no 40 S subunits could be detected at all. However, when 
the dissociation was performed in the presence of purified RNase inhibitor, 
which neutralises the action of RNase, the small subunits are preserved as 
could be demonstrated by ultracentrifugal analysis as shown in figure 21. 
It has to be mentioned that in a number of polysome preparations from calf 
lens RNase was absent, so the addition of RNase inhibitor during dissociation 
was not necessary. 
7.6. DISCUSSION 
Polyribosomes are very sensitive to the action of RNase. This was not only 
observed in animal organs (Benedetti et al., 1966; Hawtrey and Nourse, 1966; 
Tsukada et al., 1966; Appel et al., 1967; Rowley and Morris, 1967) but also 
in Escherichia cod (Fenwick, 1968; Erdman et al., 1968) and other microorgan-
isms (Flessel et al., 1967; Marcus et al., 1967; Oppenheim et al., 1968; Piati-
gorski, 1968). 
De Lamirande et al. (1967) reported the presence of an endoribonuclease -
active at pH 8 - in rat liver ribosomes, whereas the membranes contained high 
activities of phosphodiesterase and 5'-RNase. The localization of the latter two 
enzymes differs from that in bacteria since the bacterial enzymes were found 
in the ribosomes (Spahr and Hollingworth, 1961). 
The function of these enzymes in nucleic acid degradation is well established. 
Whether these enzymes are directly involved in nucleic acid and protein bio-
synthesis can not be answered yet. 
Utsunomiya and Roth (1966) observed considerably less heavy polysomes in 
rat hepatomas. A larger proportion of monomer and dimer ribosomes were 
found in this tissue. This scarcity of heavy polysomes might be due either 
to a high RNase activity in the microsomal and ribosomal fraction or to the 
presence of a relatively small amount of RNase inhibitor. 
From adsorption experiments of RNase onto 80 S ribosomes and ribosomal 
subunits of rat liver Utsunomiya and Roth (1966b) suggested that RNase is not 
a normal structural component of the 80 S ribosome or polysome. The riboso-
mal subunits, however, actively adsorb RNase. Such RNase containing sub-
units, may reaggregate under favourable conditions to form an artificial ribo-
some which is indistinguishable from the 'native' ribosome. When such artificial 
ribosomes become attached to messenger RNA, forming polysomes, the RNase 
may degrade the messenger RNA. A tentative scheme for this hypothesis was 
given by Roth (1967). 
Rahman and Cerny (1969) and Rahman et al. (1969) reported an increase 
75 
of the ribonucleases present in rat liver (ribonuclease I, II and III, their pH 
optimum being 5.0 to 5.8, 7.8 to 8.0 and 9.0 to 9.5 respectively) during the 
first few hours after partial hepatectomy, whereas RNA synthesis was stimulated 
soon after hepatectomy. Ribonuclease II activity, however, decreased between 
8 and 24 hours after partial hepatectomy. This phenomenon was also observed 
by Shortman (1962b). This author also found that the ribonuclease II inhibitor 
increased at 12 hours after partial hepatectomy with a maximum at 48 hours. 
There are indications that ribonuclease II is responsible for the degradation 
of mRNA in rat liver in vivo (Hymer and Kuff, 1964; Bont et al., 1965; Blobel 
and Potter, 1966). Whether this degradation occurs directly or after adsorption 
of the enzyme onto the 80 S particle as was hypothetically suggested by Roth 
(1967) remains to be answered. 
Ribonuclease II decreased between 8 and 24 hours after partial hepatectomy. 
At the same time protein synthesis reached its maximum rate (Majumdar et al., 
1967). Polyribosomes in regenerating liver contain less 'active' RNase (Tsukada 
et al., 1966; Arora et al., 1967), and are more stable than the polyribosomes 
from control liver (Bont et al., 1967). 
Al these facts and also our results support the view that RNase II is involved 
in mRNA breakdown during protein biosynthesis as was suggested by Brewer 
et al. (1969). 
Our observation concerning the breakdown of the small ribosomal subunit, 
described in this chapter, suggests a second mechanism in which RNase II is 
involved in protein biosynthesis. 
There is little evidence concerning the exact function of ribonuclease inhibi-
tor. It has been shown to increase in the liver of rats after partial hepatectomy 
(Shortman, 1962b; Tsukada, 1969; Moriyama et al., 1969). 
However, intracellular ribonuclease does not exist in a free form but is bound 
for the major part by ribonuclease inhibitor (Roth, 1956, 1958a, 1958b, 1962; 
Roth and Wojnar, 1961; Shortman, 1961, 1962a, 1962b) and the enzyme is to 
a small extent attached to ribosomes (Tsukada et al., 1966; Utsunomiya and 
Roth, 1966). 
It may well be that a decrease in active intracellular RNase II concentrations, 
as observed by Shortman (1962b), is due to an increase of the RNase inhibitor 
concentration. Hence the RNase inhibitor determines the effective RNase con-
centration and consequently it influences the rate of protein biosynthesis after 
partial hepatectomy. 
If this suggestion is true it is very reasonable to suppose that in normal liver 
ribonuclease inhibitor also has some regulatory function in protein bio-
synthesis. 
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SUMMARY 
In this thesis the isolation, characterization and biological function of an 
RNase inhibitor from rat liver is described. 
The following criteria have been applied in the purification procedure: firstly 
the obtainance of an increased specific activity (number of inhibitor units per 
mg of protein) of the purified fraction as compared with that of the starting 
material and secondly a simplified protein pattern in Polyacrylamide gel elec­
trophoresis. 
A purification of about 3000 times could be achieved by means of ammonium 
sulphate precipitation, chromatography on DEAE-Sephadex and gel filtration 
on Sephadex G-IOO. Even after purification to such an extent the Polyacrylamide 
gel electrophoretic pattern of the most purified fraction was still rather complex, 
showing a number of mainly fast-moving components. Chromatography on 
polymer-bound RNase columns resulted in a considerable purification of the 
inhibitor fraction obtained after gel filtration on Sephadex G-100. That a high 
degree of purity was achieved by this procedure was deduced from the obser­
vation that high inhibitory activities were present in fractions with an extremely 
low protein content. As a consequence of the low protein concentration it was 
not feasible to determine the specific inhibitor activity of the fractions obtained 
after chromatography on a CM-RNase column. An alternative to this problem 
might be the use of larger CM-RNase columns which enables an isolation pro­
cedure of the RNase inhibitor on a larger scale. At any rate we believe to 
have opened up the possibility for a final purification which requires further 
investigation. 
The RNase inhibitor activity could be characterised as to be inherent in a 
protein component as treatment with proteolytic enzymes resulted in a complete 
inactivation of the inhibitor. 
The correlation between the amount of inhibitor added and the percentage 
of inhibition of RNase was linear in the range below 1.5 units of RNase inhi­
bitor (one unit of RNase inhibitor activity is defined as the amount of inhibitor 
which causes 50 % inhibition of 0.005 μg of RNase under standard conditions). 
The pH optimum of pancreatic RNase was found to be at pH 7.8-8.0, 
whereas the RNase inhibitor showed an optimal activity in the range of pH 
7.0 to pH 8.0. 
The RNase activity was strongly inhibited by Mg 2 + ions and high ionic 
strength. Probably the observed influence of Mg 2 + ions in the RNase inhibitor 
assay was not a consequence of a diminished complex formation but could 
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fully be ascribed to inhibition of the enzyme activity, whereas the ionic strength 
was shown to influence the complex formation directly. 
The RNase inhibitor was shown to be rather stable at slightly acid pH values 
(pH 5-6). At neutral or slightly alkaline pH values the RNase inhibitor activity 
could be preserved in the presence of DTT and EDTA. As reducing agents as 
well as sulphydryl blocking agents strongly influence the activity of the RNase 
inhibitor it might be concluded that the presence of free -SH groups in the 
inhibitor is essential for its activity. 
The RNase inhibitor acts specifically on alkaline RNase as no activity was 
found against DNase. 
It is reasonable to assume that the RNase inhibitor has a function in the 
regulation of protein biosynthesis as we were able to demonstrate a protective 
effect of the inhibitor on polyribosomes as well as on ribosomal subunits. 
By inhibiting the action of endogenous RNase the inhibitor is able to preserve 
the integrity of rat liver polyribosomes as was demonstrated by sucrose density 
gradient analysis and by amino acid incorporation studies on the polyribo-
somes. That the RNase inhibitor is responsible for this protecting effect could 
be concluded from the observation that the degree of purification calculated 
from the inhibition of RNase in the standard RNase inhibitor assay, was 
parallelled by a concomitant purification of the stabilizing effect on the poly-
ribosomes. 
Meanwhile unpurified rat liver supernatant has successfully been used by 
many authors as an RNase inhibitor source for the isolation of intact polyri-
bosomes from organs of different animal species. However it is strongly re-
commended to use a more purified inhibitor preparation. Firstly because less 
inactive protein has to be added and secondly rat liver supernatant appeared 
to contain some factor which causes an inhibitory effect on the amino acid 
incorporation as was demonstrated in the case of calf lens polyribosomes. This 
factor could be eliminated by gel filtration on Sephadex G-100. 
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SAMENVATTING 
In dit proefschrift is een onderzoek beschreven over de isolatie, karakteri­
sering en biologische werking van een RNase remmer uit rattenlever. 
Voor de zuivering golden de volgende criteria. Ten eerste : Het verkrijgen van 
een grotere specifieke activiteit (aantal eenheden remmer per mg eiwit) van de 
gezuiverde fractie, vergeleken met die van het uitgangsmateriaal en ten tweede: 
Een kleiner aantal eiwitbanden in het electroforese patroon op Polyacrylamide 
gels. 
Door middel van ammoniumsulfaat-precipitatie, chromatografie op DEAE-
Sephadex en gel-filtratie op Sephadex G-100 kon een zuivering van ongeveer 
3000 maal bereikt worden. Zelfs na een dergelijke mate van zuivering echter 
vertoonde het patroon op Polyacrylamide gels van de meest gezuiverde fractie 
nog een aantal, voornamelijk snel-lopende eiwitbanden. Door chromatografie 
op een polymeer-gebonden RNase kolom kon het preparaat, verkregen na gel-
filtratie op Sephadex G-100, nog aanzienlijk worden gezuiverd. Dat door middel 
van deze procedure een hoge mate van zuiverheid van de remmer werd bereikt 
kon geconcludeerd worden uit het feit, dat een hoge remmende activiteit 
werd gevonden in fracties met een zeer lage eiwitconcentratie. Als gevolg van 
deze lage eiwitconcentratie was het niet mogelijk om de specifieke activiteit te 
bepalen van de fractie, verkregen na chromatografie op een CM-RNase kolom. 
Een alternatief voor dit probleem zou het gebruik kunnen zijn van een grotere 
CM-RNase kolom, waardoor de isolatieprocedure van de RNase remmer op 
grotere schaal mogelijk zou zijn. Hoewel deze methode nog verder uitgewerkt 
zal moeten worden, menen wij dat het op deze manier mogelijk is om een 
uiteindelijke zuivering van de RNase remmer te verkrijgen. 
De activiteit van de RNase remmer bleek inherent te zijn aan een eiwitcom­
ponent aangezien behandeling met proteolytische enzymen leidde tot een vol­
ledige inactivering van de remmer. 
De relatie tussen de hoeveelheid toegevoegde RNase remmer en het daardoor 
veroorzaakte percentage remming van RNase bleek liniair te zijn in het gebied 
beneden 1,5 eenheid (een eenheid RNase remmer activiteit is die hoeveelheid, 
die 50 % remming veroorzaakt van 0,005 μg RNase onder standaard condities). 
Het pH optimum van pancreas RNase ligt bij pH 7,8-8,0 terwijl de RNase 
remmer een optimale activiteit vertoonde in het gebied van pH 7,0-8,0. 
De RNase activiteit werd sterk geremd door de aanwezigheid van Mg 2 + ionen 
en door hoge ionsterkte. Waarschijnlijk was het effect van Mg 2 + ionen op de 
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RNase remmer niet het gevolg van een verminderde complexvorming tussen 
enzym en remmer, maar kon volledig worden toegeschreven aan een verlaagde 
RNase activiteit, terwijl de ionsterkte de complexvorming direct beïnvloedde. 
De RNase remmer bleek vrij stabiel te zijn bij zwak zure pH (pH 5-6). Bij 
neutrale of zwak alkalische pH kon de activiteit van de RNase remmer worden 
behouden in aanwezigheid van DTT en EDTA. Omdat zowel reducerende als 
sulfhydryl-blokkerende reagentia de activiteit van de RNase remmer sterk be-
ïnvloeden, zou daaruit geconcludeerd kunnen worden, dat de aanwezigheid van 
vrije -SH groepen in de remmer essentieel is voor zijn activiteit. 
De RNase remmer reageert specifiek op alkalische RNase, want ten opzichte 
van DNase werd geen activiteit waargenomen. 
Het is aannemelijk, dat de RNase remmer een functie heeft in de regulatie 
van de eiwitbiosynthese, omdat hij een beschermend effect bleek te hebben zowel 
op polyribosomen als op ribosomale subeenheden. 
Door de werking van endogeen RNase uit te schakelen is de remmer in staat 
om de integriteit van rattenlever-polysomen te bewaren, zoals kon worden aan-
getoond aan de hand van patronen op sucrose gradiënten als ook aan het be-
houd van het vermogen van de polyribosomen om aminozuren in te bouwen. 
Dat de RNase remmer inderdaad verantwoordelijk is voor dit stabiliserend ef-
fect kon worden geconcludeerd uit het feit, dat de mate van zuivering gebaseerd 
op de remming van RNase in het standaard incubatiemengsel, gepaard gaat 
met de zuivering van de polyribosomen-beschermende factor. 
De RNase remmer bleek ook actief te zijn op het niveau van ribosomale 
subeenheden, door het 40S deeltje intact te houden gedurende dissociatie, zoals 
kon worden aangetoond met kalfslens polysomen. 
Ondertussen is ongezuiverde rattenlever supernatant door vele onderzoekers 
met succes als RNase remmer gebruikt om intacte polyribosomen uit organen 
van verschillende diersoorten te isoleren. Het verdient echter aanbeveling om 
daarvoor een meer gezuiverd preparaat te gebruiken. Op de eerste plaats hoeft 
daarvan minder inactief eiwit te worden toegevoegd, op de tweede plaats bevat 
rattenlever-supernatant blijkbaar een factor, die remmend werkt op de amino-
zuurinbouw, zoals werd aangetoond met kalfslenspolysomen. Deze factor kon 
echter geëlimineerd worden door gel-filtratie op Sephadex G-100. 
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